Willem Fibbe
Hoogleraar Hematologie, in het bijzonder stamcelbiologie
- Naam
- Prof.dr. W.E. Fibbe
- Telefoon
- +31 71 526 2271
- w.e.fibbe@lumc.nl
- ORCID iD
- 0000-0001-8539-9011
De profieltekst van Prof.dr. Willem Fibbe is momenteel alleen op de Engelstalige pagina beschikbaar.
Hoogleraar Hematologie, in het bijzonder stamcelbiologie
- Faculteit Geneeskunde
- Divisie 2
- Hematologie
- Hematologie algemeen
- Reinders, M.E.J.; Groeneweg, K.E.; Hendriks, S.H.; Bank, J.R.; Dreyer, G.J.; Vries, A.P.J. de; Pel, M. van; Roelofs, H.; Huurman, V.A.L.; Meij, P.; Moes, D.J.A.R.; Fibbe, W.E.; Claas, F.H.J.; Roelen, D.L.; Kooten, C. van; Kers, J.; Heidt, S.; Rabelink, T.J. & Fijter, J.W. de (2021), Autologous bone marrow-derived mesenchymal stromal cell therapy with early tacrolimus withdrawal, American Journal of Transplantation 21(9).
- Hidalgo-Simon, A. & Fibbe, W.E. (2021), Advanced therapies are ready to take centre stage: academia's involvement with regulation needs to raise its game, British Journal of Clinical Pharmacology 87(6): 2412-2413.
- Dreyer, G.J.; Groeneweg, K.E.; Heidt, S.; Roelen, D.L.; Pel, M. van; Roelofs, H.; Huurman, V.A.L.; Bajema, I.M.; Moes, D.J.A.R.; Fibbe, W.E.; Claas, F.H.J.; Kooten, C. van; Rabelink, R.J.; Fijter, J.W. de & Reinders, M.E.J. (2020), Human leukocyte antigen selected allogeneic mesenchymal stromal cell therapy in renal transplantation, American Journal of Transplantation 20(10).
- Staal, F.J.T. & Fibbe, W.E. (2020), BETting on stem cell expansion, Blood 136(21): 2364-2365.
- Kruijf, E.J.F.M. de; Fibbe, W.E. & Pel, M. van (2020), Cytokine-induced hematopoietic stem and progenitor cell mobilization: unraveling interactions between stem cells and their niche, Annals of the New York Academy of Sciences 1466(1): 24-38.
- Kruijf, E.J.F.M. de; Zuijderduijn, R.; Stip, M.C.; Fibbe, W.E. & Pel, M. van (2018), Mesenchymal stromal cells induce a permissive state in the bone marrow that enhances G-CSF-induced hematopoietic stem cell mobilization in mice, Experimental Hematology.
- Kruijf, E.J.F.M. de; Zuijderduijn, R.; Stip, M.C.; Fibbe, W.E. & Pel, M. van (2018), Mesenchymal stromal cells induce a permissive state in the bone marrow that enhances G-CSF-induced hematopoietic stem cell mobilization in mice, Experimental Hematology 64: 59-70.
- Thielen, F.W.; Blommestein, H.M.; Oosten, L.E.M.; Calkoen, F.G.; Lankester, A.C.; Zwaginga, J.J.; Blanc, K. le; Redondo, A.; Sanchez-Guijo, F.; Algeri, M.; Locatelli, F.; Fibbe, W.E. & Uyl-de Groot, C.A. (2018), Second-line treatment for acute graft-versus-host disease with mesenchymal stromal cells: A decision model, European Journal of Haematology 101(5): 676-683.
- Lindeman, J.H.N.; Zwaginga, J.J.; Kallenberg-Lantrua, G.; Wissen, R.C. van; Schepers, A.; Bockel, H.J. van; Fibbe, W.E. & Hamming, J.F. (2018), No Clinical Benefit of Intramuscular Delivery of Bone Marrow-derived Mononuclear Cells in Nonreconstructable Peripheral Arterial Disease Results of a Phase-III Randomized-controlled Trial, Annals of Surgery 268(5): 756-761.
- Trento, C.; Bernardo, M.E.; Nagler, A.; Kuci, S.; Bornhauser, M.; Kohl, U.; Strunk, D.; Galleu, A.; Sanchez-Guijo, F.; Gaipa, G.; Introna, M.; Bukauskas, A.; Blanc, K. le; Apperley, J.; Roelofs, H.; Campenhout, A. van; Beguin, Y.; Kuball, J.; Lazzari, L.; Avanzini, M.A.; Fibbe, W.; Chabannon, C.; Bonini, C. & Dazzi, F. (2018), Manufacturing Mesenchymal Stromal Cells for the Treatment of Graft-versus-Host Disease: A Survey among Centers Affiliated with the European Society for Blood and Marrow Transplantation, Biology of Blood and Marrow Transplantation 24(11): 2365-2370.
- Aleksinskaya, M.A.; Monge, M.; Siebelt, M.; Slot, E.M.; Koekkoek, K.M.; Bruin, R.G. de; Massy, Z.A.; Weinans, H.; Rabelink, T.J.; Fibbe, W.E.; Zonneveld, A.J. van & Pel, M. van (2018), Chronic kidney failure mineral bone disorder leads to a permanent loss of hematopoietic stem cells through dysfunction of the stem cell niche, Scientific Reports 8.
- Fibbe, W. & Gale, R.P. (2017), Johannes Joseph van Rood: pioneer in immuno-genetics (7 April 1926-21 July 2017) OBITUARY, Bone Marrow Transplantation 52(11): 1485-1486.
- Fibbe, W. & Gale, R.P. (2017), Johannes Joseph van Rood Pioneer in immuno-genetics (7 April 1926-21 July 2017) OBITUARY, Leukemia 31(11): 2286-2287.
- Fibbe, W.E. & Rabelink, T.J. (2017), Mesenchymal stromal cells in lupus nephritis, Nature Reviews Nephrology 13(8): 453-454.
- Rodrigo, S.F.; Mann, I.; Ramshorst, J. van; Beeres, S.L.; Zwaginga, J.J.; Fibbe, W.E.; Bax, J.J.; Schalij, M.J. & Atsma, D.E. (2017), Safety and efficacy of percutaneous intramyocardial bone marrow cell injection for chronic myocardial ischemia: Long-term results, Journal of Interventional Cardiology 30(5): 440-447.
- Thielen, F.; Blommestein, H.M.; Oosten, L.; Fibbe, W.; Blanc, K. le; Locatelli, F.; Sanchez-Guijo, F.; Calkoen, F.; Lankester, A.; Algeri, M.; Redondo-Guijo, A. & Uyl-de Groot, C.A. (2017), SECOND-LINE TREATMENT FOR STEROID-REFRACTORY GRAFT-VERSUS-HOST DISEASE WITH MESENCHYMAL STROMAL CELLS. A CONCEPTUAL DISEASE MODEL, Value in Health 20(9): A545-A546.
- Leuning, D.G.; Reinders, M.E.J.; Li, J.; Peired, A.J.; Lievers, E.; Boer, H.C. de; Fibbe, W.E.; Romagnani, P.; Kooten, C. van; Little, M.H.; Engelse, M.A. & Rabelink, T.J. (2017), Clinical-Grade Isolated Human Kidney Perivascular Stromal Cells as an Organotypic Cell Source for Kidney Regenerative Medicine, Stem Cells Translational Medicine 6(2): 405-418.
- Stolk, J.; Broekman, W.; Mauad, T.; Zwaginga, J.J.; Roelofs, H.; Fibbe, W.E.; Oostendorp, J.; Bajema, I.; Versteegh, M.I.M.; Taube, C. & Hiemstra, P.S. (2016), A phase I study for intravenous autologous mesenchymal stromal cell administration to patients with severe emphysema, QJM: An International Journal of Medicine 109(5): 331-336.
- Haan, M.C. den; Zuylen, V.L. van; Pluijmert, N.J.; Schutte, C.I.; Fibbe, W.E.; Schalij, M.J.; Roelofs, H. & Atsma, D.E. (2016), Discrepant Results of Experimental Human Mesenchymal Stromal Cell Therapy after Myocardial Infarction: Are Animal Models Robust Enough?, PLoS ONE 11(4).
- Rodrigo, S.F.; Mann, I.; Rarnshorst, J. van; Beeres, S.L.M.A.; Zwaginga, J.J.; Fibbe, W.E.; Bax, J.J.; Schalij, M.J. & Atsma, D.E. (2016), Reduction of healthcare utilization after bone marrow cell therapy for refractory angina pectoris, International Journal of Cardiology 202: 571-572.
- Galipeau, J.; Krampera, M.; Barrett, J.; Dazzi, F.; Deans, R.J.; Debruijn, J.; Dominici, M.; Fibbe, W.E.; Gee, A.P.; Gimble, J.M.; Hematti, P.; Koh, M.B.C.; Leblanc, K.; Martin, I.; McNiece, I.K.; Mendicino, M.; Oh, S.; Ortiz, L.; Phinney, D.G.; Planat, V.; Shi, Y.F.; Stroncek, D.F.; Viswanathan, S.; Weiss, D.J. & Sensebe, L. (2016), International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials, Cytotherapy 18(2): 151-159.
- Wiekmeijer, A.S.; Pike-Overzet, K.; IJspeert, H.; Brugman, M.H.; Wolvers-Tettero, I.L.M.; Lankester, A.C.; Bredius, R.G.M.; Dongen, J.J.M. van; Fibbe, W.E.; Langerak, A.W.; Burg, M. van der & Staal, F.J.T. (2016), Identification of checkpoints in human T-cell development using severe combined immunodeficiency stem cells, Journal of Allergy and Clinical Immunology 137(2): 517-+.
- Engert, A.; Balduini, C.; Brand, A.; Coiffier, B.; Cordonnier, C.; Dohner, H.; Wit, T.D. de; Eichinger, S.; Fibbe, W.; Green, T.; Haas, F. de; Iolascon, A.; Jaffredo, T.; Rodeghiero, F.; Salles, G.; Schuringa, J.J.; Andre, M.; Andre-Schmutz, I.; Bacigalupo, A.; Bochud, P.Y.; Boer, M. den; Bonini, C.; Camaschella, C.; Cant, A.; Cappellini, M.D.; Cazzola, M.; Celso, C. lo; Dimopoulos, M.; Douay, L.; Dzierzak, E.; Einsele, H.; Ferreri, A.; Franceschi, L. de; Gaulard, P.; Gottgens, B.; Greinacher, A.; Gresele, P.; Gribben, J.; Haan, G. de; Hansen, J.B.; Hochhaus, A.; Kadir, R.; Kaveri, S.; Kouskoff, V.; Kuhne, T.; Kyrle, P.; Ljungman, P.; Maschmeyer, G.; Mendez-Ferrer, S.; Milsom, M.; Mummery, C.; Ossenkoppele, G.; Pecci, A.; Peyvandi, F.; Philipsen, S.; Reitsma, P.; Ribera, J.M.; Risitano, A.; Rivella, S.; Ruf, W.; Schroeder, T.; Scully, M.; Socie, G.; Staal, F.; Stanworth, S.; Stauder, R.; Stilgenbauer, S.; Tamary, H.; Theilgaard-Monch, K.; Thein, S.L.; Tilly, H.; Trneny, M.; Vainchenker, W.; Vannucchi, A.M.; Viscoli, C.; Vrielink, H.; Zaaijer, H.; Zanella, A.; Zolla, L.; Zwaginga, J.J.; Martinez, P.A.; Akker, E. van den; Allard, S.; Anagnou, N.; Andolfo, I.; Andrau, J.C.; Angelucci, E.; Anstee, D.; Aurer, I.; Avet-Loiseau, H.; Aydinok, Y.; Bakchoul, T.; Balduini, A.; Barcellini, W.; Baruch, D.; Baruchel, A.; Bayry, J.; Bento, C.; Berg, A. van den; Bernardi, R.; Bianchi, P.; Bigas, A.; Biondi, A.; Bohonek, M.; Bonnet, D.; Borchmann, P.; Borregaard, N.; Braekkan, S.; Brink, M. van den; Brodin, E.; Bullinger, L.; Buske, C.; Butzeck, B.; Cammenga, J.; Campo, E.; Carbone, A.; Cervantes, F.; Cesaro, S.; Charbord, P.; Claas, F.; Cohen, H.; Conard, J.; Coppo, P.; Corrons, J.L.V.; Costa, L. da; Davi, F.; Delwel, R.; Dianzani, I.; Domanovic, D.; Donnelly, P.; Drnovsek, T.D.; Dreyling, M.; , M.Q. du; Dufour, C.; Durand, C.; Efremov, D.; Eleftheriou, A.; Elion, J.; Emonts, M.; Engelhardt, M.; Ezine, S.; Falkenburg, F.; Favier, R.; Federico, M.; Fenaux, P.; Fitzgibbon, J.; Flygare, J.; Foa, R.; Forrester, L.; Galacteros, F.; Garagiola, I.; Gardiner, C.; Garraud, O.; Geet, C. van; Geiger, H.; Geissler, J.; Germing, U.; Ghevaert, C.; Girelli, D.; Godeau, B.; Gokbuget, N.; Goldschmidt, H.; Goodeve, A.; Graf, T.; Graziadei, G.; Griesshammer, M.; Gruel, Y.; Guilhot, F.; Gunten, S. von; Gyssens, I.; Halter, J.; Harrison, C.; Harteveld, C.; Hellstrom-Lindberg, E.; Hermine, O.; Higgs, D.; Hillmen, P.; Hirsch, H.; Hoskin, P.; Huls, G.; Inati, A.; Johnson, P.; Kattamis, A.; Kiefel, V.; Kleanthous, M.; Klump, H.; Krause, D.; Hovinga, J.K.; Lacaud, G.; Lacroix-Desmazes, S.; Landman-Parker, J.; LeGouill, S.; Lenz, G.; Lilienfeld-Toal, M. von; Lindern, M. von; Lopez-Guillermo, A.; Lopriore, E.; Lozano, M.; MacIntyre, E.; Makris, M.; Makris, M.; Martens, J.; Mathas, S.; Matzdorff, A.; Medvinsky, A.; Menendez, P.; Migliaccio, A.R.; Miharada, K.; Mikulska, M.; Minard, V.; Montalban, C.; Montalembert, M. de; Montserrat, E.; Morange, P.E.; Mountford, J.; Muckenthaler, M.; Muller-Tidow, C.; Mumford, A.; Nadel, B.; Navarro, J.T.; Nemer, W. el; Noizat-Pirenne, F.; O'Mahony, B.; Oldenburg, J.; Olsson, M.; Oostendorp, R.; Palumbo, A.; Passamonti, F.; Patient, R.; Latour, R.P. de; Pflumio, F.; Pierelli, L.; Piga, A.; Pollard, D.; Raaijmakers, M.; Radford, J.; Rambach, R.; Rao, A.K.; Raslova, H.; Rebulla, P.; Rees, D.; Ribrag, V.; Rijneveld, A.; Rinalducci, S.; Robak, T.; Roberts, I.; Rodrigues, C.; Rosendaal, F.; Rosenwald, A.; Rule, S.; Russo, R.; Saglio, G.; Sanchez, M.; Scharf, R.E.; Schlenke, P.; Semple, J.; Sierra, J.; So-Osman, C.; Soria, J.M.; Stamatopoulos, K.; Stegmayr, B.; Stunnenberg, H.; Swinkels, D.; Barata, J.P.T.; Taghon, T.; Taher, A.; Terpos, E.; Thachil, J.; Tissot, J.D.; Touw, I.; Toye, A.; Trappe, R.; Traverse-Glehen, A.; Unal, S.; Vaulont, S.; Viprakasit, V.; Vitolo, U.; Wijk, R. van; Wojtowicz, A.; Zeerleder, S.; Zieger, B. & EHA Roadmap European Hematology Re (2016), The European Hematology Association Roadmap for European Hematology Research: a consensus document, Haematologica 101(2): 115-208.
- Pel, M. van; Fibbe, W.E.; Schepers, K.; Kanz, L.; Fibbe, W.E.; Skokowa, J. & Dick, J.E. (2016), The human and murine hematopoietic stem cell niches: are they comparable?, Annals of the New York Academy of Sciences 1370: 55-64.
- Fibbe, W.E. (2016), Therapeutic immune regulation by mesenchymal stromal cells, Human Gene Therapy 27(11): A16-A16.
- Staal, F.J.T.; Spaink, H.P. & Fibbe, W.E. (2016), Visualizing Human Hematopoietic Stem Cell Trafficking In Vivo Using a Zebrafish Xenograft Model, Stem Cells and Development 25(4): 360-365.
- Schepers, K.; Fibbe, W.E.; Kanz, L.; Fibbe, W.E.; Skokowa, J. & Dick, J.E. (2016), Unraveling mechanisms of mesenchymal stromal cell-mediated immunomodulation through patient monitoring and product characterization, Annals of the New York Academy of Sciences 1370: 15-23.
- Reinders, M.E.J.; Dreyer, G.J.; Bank, J.R.; Roelofs, H.; Heidt, S.; Roelen, D.L.; Zandvliet, M.L.; Huurman, V.A.L.; Fibbe, W.E.; Kooten, C. van; Claas, F.H.J.; Rabelink, T.J. & Fijter, J.W. de (2015), Safety of allogeneic bone marrow derived mesenchymal stromal cell therapy in renal transplant recipients: the neptune study, Journal of Translational Medicine 13.
- Pike-Overzet, K.; Wiekmeijer, A.S.; Brugman, M.H.; Wolvers-Tettero, I.L.; Lankester, A.C.; Bredius, R.G.; Dongen, J.J. van; Fibbe, W.E.; Langerak, A.W.; Burg, M. van der & Staal, F.J. (2015), Transplantation of human SCID stem cells in NSG mice gives new insights into human T-cell development, Human Gene Therapy 26(10): A59-A59.
- Mann, I.; Rodrigo, S.F.; Ramshorst, J. van; Beeres, S.L.M.A.; Lamb, H.J.; Siebelink, H.M.; Geest, R.J. van der; Fibbe, W.E.; Schalij, M.J. & Atsma, D.E. (2015), Presence of myocardial scar does not prevent improvement in myocardial perfusion and left ventricular function in refractory angina patients undergoing intramyocardial bone marrow cell injection, European Heart Journal 36: 353-353.
- Zuylen, V.L. van; Haan, M.C. den; Roelofs, H.; Fibbe, W.E.; Schalij, M.J. & Atsma, D.E. (2015), Myocardial infarction models in NOD/Scid mice for cell therapy research: permanent ischemia vs ischemia-reperfusion, Springerplus 4.
- Zuylen, V.L. van; Haan, M.C. den; Geutskens, S.B.; Roelofs, H.; Fibbe, W.E.; Schalij, M.J. & Atsma, D.E. (2015), Post-myocardial Infarct Inflammation and the Potential Role of Cell Therapy, Cardiovascular Drugs and Therapy 29(1): 59-73.
- Bernardo, M.E. & Fibbe, W.E. (2015), Mesenchymal stromal cells and hematopoietic stem cell transplantation, Immunology Letters 168(2): 215-221.
- Molendijk, I.; Bonsing, B.A.; Roelofs, H.; Peeters, K.C.; Wasser, M.N.; Veenendaal, R.A.; Zwaginga, J.J.; Verspaget, H.W.; Fibbe, W.E.; Meulen-de Jong, A.E. van der & Hommes, D.W. (2015), Unblinded Results from a dose-escalating placebo-controlled study with allogeneic bone marrow-derived mesenchymal stem cells for the treatment of refractory perianal fistulas in patients with Crohn's disease, Journal of Crohn's and Colitis 9: S254-S255.
- Brugman, M.H.; Wiekmeijer, A.S.; Eggermond, M. van; Wolvers-Tettero, I.; Langerak, A.W.; Haas, E.F.E. de; Bystrykh, L.V.; Rood, J.J. van; Haan, G. de; Fibbe, W.E. & Staal, F.J.T. (2015), Development of a diverse human T-cell repertoire despite stringent restriction of hematopoietic clonality in the thymus, Proceedings of the National Academy of Sciences 112(44): E6020-E6027.
- Alexander, T.; Bondanza, A.; Muraro, P.A.; Greco, R.; Saccardi, R.; Daikeler, T.; Kazmi, M.; Hawkey, C.; Simoes, P.; Leblanc, K.; Fibbe, W.E.; Moore, J.; Snarski, E.; Martin, T.; Hiepe, F.; Velardi, A.; Toubert, A.; Snowden, J.A.; Farge, D.; EBMT Autoimmune Dis Working Party & Immunobiology Working Party (2015), SCT for severe autoimmune diseases: consensus guidelines of the European Society for Blood and Marrow Transplantation for immune monitoring and biobanking, Bone Marrow Transplantation 50(2): 173-180.
- Rosen, C.; Shezen, E.; Aronovich, A.; Klionsky, Y.Z.; Yaakov, Y.; Assayag, M.; Biton, I.E.; Tal, O.; Shakhar, G.; Ben-Hur, H.; Shneider, D.; Vaknin, Z.; Sadan, O.; Evron, S.; Freud, E.; Shoseyov, D.; Wilschanski, M.; Berkman, N.; Fibbe, W.E.; Hagin, D.; Hillel-Karniel, C.; Krentsis, I.M.; Bachar-Lustig, E. & Reisner, Y. (2015), Preconditioning allows engraftmentof mouse and human embryonic lung cells, enabling lung repair in mice, Nature Medicine 21(8): 869-879.
- Mann, I.; Rodrigo, S.F.; Ramshorst, J. van; Beeres, S.L.; Dibbets-Schneider, P.; Roos, A. de; Wolterbeek, R.; Zwaginga, J.J.; Fibbe, W.E.; Bax, J.J.; Schalij, M.J. & Atsma, D.E. (2015), Repeated Intramyocardial Bone Marrow Cell Injection in Previously Responding Patients With Refractory Angina Again Improves Myocardial Perfusion, Anginal Complaints, and Quality of Life, Circulation: Cardiovascular Interventions 8(8).
- Molendijk, I.; Bonsing, B.A.; Roelofs, H.; Peeters, K.C.M.J.; Wasser, M.N.J.M.; Dijkstra, G.; Woude, C.J. van der; Duijvestein, M.; Veenendaal, R.A.; Zwaginga, J.J.; Verspaget, H.W.; Fibbe, W.E.; Meulen-de Jong, A.E. van der & Hommes, D.W. (2015), Allogeneic Bone Marrow-Derived Mesenchymal Stromal Cells Promote Healing of Refractory Perianal Fistulas in Patients With Crohn's Disease.
- Molendijk, I.; Bonsing, B.A.; Roelofs, H.; Peeters, K.C.M.J.; Wasser, M.N.J.M.; Dijkstra, G.; Woude, C.J. van der; Veenendaal, R.A.; Zwaginga, J.J.; Verspaget, H.W.; Fibbe, W.E.; Meulen-de Jong AE van der & Hommes, D.W. (2015), Allogeneic bone marrow-derived mesenchymal stromal stem cells for the treatment of refractory perianal Crohn fistulas: a dose-escalating placebo-controlled study, Journal of Crohn's and Colitis 9: S32-S33.
- Mann, I.; Rodrigo, S.; Ramshorst, J. van; Beeres, S.; Roos, A. de; Bax, J.; Fibbe, W.E.; Schalij, M. & Atsma, D. (2014), PREVIOUSLY RESPONDING NO-OPTION PATIENTS WITH RESIDUAL OR RECURRENT REFRACTORY ANGINA PECTORIS AND DOCUMENTED ISCHEMIA BENEFIT FROM REPEAT INTRAMYOCARDIAL INJECTION OF AUTOLOGOUS BONE MARROW CELLS, Journal of the American College of Cardiology 63(12): A1595-A1595.
- Molendijk, I.; Galarza, J.M.P.; Jonge-Muller, E.S. de; Meulen-de Jong, A.E. van der; Fibbe, W.E.; Hommes, D.W.; Pel, M. van & Verspaget, H.W. (2014), Intraperitoneally injected mesenchymal stromal cells home significantly more often to the intestines in colitis mice compared to healthy controls, Journal of Crohn's and Colitis 8: S84-S84.
- Pike-Overzet, K.; Baum, C.; Bredius, R.G.M.; Cavazzana, M.; Driessen, G.J.; Fibbe, W.E.; Gaspar, H.B.; Hoeben, R.C.; Lagresle-Peyrou, C.; Lankester, A.; Meij, P.; Schambach, A.; Thrasher, A.; Dongen, J.J.M. van; Zwaginga, J.J. & Staal, F.J.T. (2014), Successful RAG1-SCID gene therapy depends on the level of RAG1 expression.
- Melief, S.; Schrama, E.; Geutskens, S.; Tiemessen, M.; Brugman, M.; Fibbe, W. & Roelofs, H. (2014), THE ROLE OF MONOCYTES IN THE IMMUNOREGULATORY FUNCTION OF MULTIPOTENT STROMAL CELLS, Cytotherapy 16(4): S72-S72.
- Kruijf, E.J.F.M. de; Alkemade, G.M.; Os, R. van; Fibbe, W.E. & Pel, M. van (2014), Peripheral blood hematopoietic stem and progenitor cell frequency is unchanged in patients with alpha-1-antitrypsin deficiency, International Journal of Hematology 99(6): 714-720.
- Hogendoorn, S.; Duijnisveld, B.J.; Duinen, S.G. van; Stoel, B.C.; Dijk, J.G. van; Fibbe, W.E. & Nelissen, R.G.H.H. (2014), Local injection of autologous bone marrow cells to regenerate muscle in patients with traumatic brachial plexus injury A PILOT STUDY, Bone and Joint Research 3(2): 38-47.
- Ramshorst, J. van; Beeres, S.L.M.A.; Rodrigo, S.F.; Dibbets-Schneider, P.; Scholte, A.J.; Fibbe, W.E.; Zwaginga, J.J.; Schalij, M.J.; Bax, J.J. & Atsma, D.E. (2014), Effect of intramyocardial bone marrow-derived mononuclear cell injection on cardiac sympathetic innervation in patients with chronic myocardial ischemia, International Journal of Cardiovascular Imaging 30(3): 583-589.
- Moll, G.; Hult, A.; Bahr, L. von; Alm, J.J.; Heldring, N.; Hamad, O.A.; Stenbeck-Funke, L.; Larsson, S.; Teramura, Y.; Roelofs, H.; Nilsson, B.; Fibbe, W.E.; Olsson, M.L. & Blanc, K. le (2014), Do ABO Blood Group Antigens Hamper the Therapeutic Efficacy of Mesenchymal Stromal Cells?, PLoS ONE 9(1).
- Brugman, M.H.; Wiekmeijer, A.; Eggermond, M.C.J.A. van; Wolvers-Terrero, I.L.M.; Langerak, A.W.; Haas, E.F.E. de; Bystrykh, L.V.; Haan, G. de; Fibbe, W.E. & Staal, F.J.T. (2014), Development of a diverse human T cell repertoire despite severe restriction of hematopoietic clonality in the thymus, Human Gene Therapy 25(11): A109-A109.
- Reinders, M.E.J.; Bank, J.R.; Dreyer, G.J.; Roelofs, H.; Heidt, S.; Roelen, D.L.; Huurman, V.A.L.; Lindeman, J.; Kooten, C. van; Claas, F.H.J.; Fibbe, W.E.; Rabelink, T.J. & Fijter, J.W. de (2014), Autologous bone marrow derived mesenchymal stromal cell therapy in combination with everolimus to preserve renal structure and function in renal transplant recipients, Journal of Translational Medicine 12.
- Mann, I.; Rodrigo, S.F.; Ramshorst, J. van; Beeres, S.L.; Roos, A. de; Bax, J.J.; Fibbe, W.E.; Schalij, M.J. & Atsma, D.E. (2014), Repeated intramyocardial cell injection again improves perfusion, anginal complaints and quality of life in previously responding cell therapy patients, European Heart Journal 35: 644-645.
- Rodrigo, S.F.; Ramshorst, J. van; Mann, I.; Leong, D.P.; Cannegieter, S.C.; Younis, I. al; Dibbets-Schneider, P.; Roos, A. de; Fibbe, W.E.; Zwaginga, J.J.; Bax, J.J.; Schalij, M.J.; Beeres, S.L. & Atsma, D.E. (2014), Predictors of response to intramyocardial bone marrow cell treatment in patients with refractory angina and chronic myocardial ischemia, International Journal of Cardiology 175(3): 539-544.
- Perez-Galarza, J.; Carlotti, F.; Rabelink, M.J.; Cramer, S.; Hoeben, R.C.; Fibbe, W.E. & Pel, M. van (2014), Optimizing reporter constructs for in vivo bioluminescence imaging of interferon-gamma stimulated mesenchymal stromal cells, Experimental Hematology 42(9): 793-803.
- Westerhuis, G.; Witte, M. de; Schumacher, T.N.; Toes, R.E.M. & Fibbe, W.E. (2014), Barriers to chimerism after major histocompatibility complex-mismatched stem cell transplantation: A potential role for heterologous immunity, Experimental Hematology 42(9): 753-760.
- Laar, J.M. van; Farge, D.; Sont, J.K.; Naraghi, K.; Marjanovic, Z.; Larghero, J.; Schuerwegh, A.J.; Marijt, E.W.A.; Vonk, M.C.; Schattenberg, A.V.; Matucci-Cerinic, M.; Voskuyl, A.E.; Loosdrecht, A.A. van de; Daikeler, T.; Kotter, I.; Schmalzing, M.; Martin, T.; Lioure, B.; Weiner, S.M.; Kreuter, A.; Deligny, C.; Durand, J.M.; Emery, P.; Machold, K.R.; Sarrot-Reynauld, F.; Warnatz, K.; Adoue, D.F.P.; Constans, J.; Tony, H.P.; Papa, N. del; Fassas, A.; Himsel, A.; Launay, D.; Monaco, A. lo; Philippe, P.; Quere, I.; Rich, E.; Westhovens, R.; Griffiths, B.; Saccardi, R.; Hoogen, F.H. van den; Fibbe, W.E.; Socie, G.; Gratwohl, A.; Tyndall, A. & EBMT EULAR Scleroderma Study Grp (2014), Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis A Randomized Clinical Trial, Journal of the American Medical Association 311(24): 2490-2498.
- Wiekmeijer, A.; Pike-Overzet, K.; Brugman, M.H.; Wolvers-Tettero, I.L.M.; Lankester, A.C.; Bredius, R.G.M.; Dongen, J.J.M. van; Fibbe, W.E.; Langerak, A.W.; Burg, M. van der & Staal, F.J.T. (2014), Transplantation of human SCID stem cells in NSG mice gives new insights into human T-cell development and reveals where SCID mutations act, Human Gene Therapy 25(11): A41-A41.
- Wiekmeijer, A.S.; Pike-Overzet, K.; Brugman, M.H.; Fibbe, W.E. & Staal, F.J.T. (2013), LMO2 Perturbs Human T Cell Development In Vivo by Two Different Mechanisms, Molecular Therapy 21: S123-S123.
- Reinders, M.E.J.; Fijter, J.W. de; Roelofs, H.; Bajema, I.M.; Vries, D.K. de; Schaapherder, A.F.; Claas, F.H.J.; Miert, P.P.M.C. van; Roelen, D.L.; Kooten, C. van; Fibbe, W.E. & Rabelink, T.J. (2013), Autologous Bone Marrow-Derived Mesenchymal Stromal Cells for the Treatment of Allograft Rejection After Renal Transplantation: Results of a Phase I Study, Stem Cells Translational Medicine 2(2): 107-111.
- Melief, S.M.; Schrama, E.; Brugman, M.H.; Tiemessen, M.M.; Hoogduijn, M.J.; Fibbe, W.E. & Roelofs, H. (2013), Multipotent Stromal Cells Induce Human Regulatory T Cells Through a Novel Pathway Involving Skewing of Monocytes Toward Anti-inflammatory Macrophages, STEM CELLS 31(9): 1980-1991.
- Reinders, M.E.J.; Roemeling-van Rhijn, M.; Khairoun, M.; Lievers, E.; Vries, D.K. de; Schaapherder, A.F.M.; Wong, S.W.S.; Zwaginga, J.J.; Duijs, J.M.; Zonneveld, A.J. van; Hoogduijn, M.J.; Fibbe, W.E.; Fijter, J.W. de; Kooten, C. van; Rabelink, T.J. & Roelofs, H. (2013), Bone marrow-derived mesenchymal stromal cells from patients with end-stage renal disease are suitable for autologous therapy, Cytotherapy 15(6): 663-672.
- Fibbe, W.E.; Dazzi, F. & LeBlanc, K. (2013), MSCs: science and trials, Nature Medicine 19(7): 812-813.
- Bernardo, M.E. & Fibbe, W.E. (2013), Mesenchymal Stromal Cells: Sensors and Switchers of Inflammation, Cell Stem Cell 13(4): 392-402.
- Wiersum-Osselton, J.C.; Walraven, S.M. van; Bank, I.; Lenselink, A.M.; Fibbe, W.E.; Bom, J.G. van der & Brand, A. (2013), Clinical outcomes after peripheral blood stem cell donation by related donors: a Dutch single-center cohort study, Transfusion 53(1): 96-103.
- Rodrigo, S.F.; Ramshorst, J. van; Hoogslag, G.E.; Boden, H.; Velders, M.A.; Cannegieter, S.C.; Roelofs, H.; Younis, I. al; Dibbets-Schneider, P.; Fibbe, W.E.; Zwaginga, J.J.; Bax, J.J.; Schalij, M.J.; Beeres, S.L. & Atsma, D.E. (2013), Intramyocardial Injection of Autologous Bone Marrow-Derived Ex Vivo Expanded Mesenchymal Stem Cells in Acute Myocardial Infarction Patients is Feasible and Safe up to 5 Years of Follow-up, Journal of Cardiovascular Translational Research 6(5): 816-825.
- Ramshorst, J. van; Rodrigo, S.F.; Beeres, S.L.M.A.; Fibbe, W.E.; Zwaginga, J.J.; Bax, J.J.; Schalij, M.J. & Atsma, D.E. (2013), Long term effects of intramyocardial bone marrow cell injection on anginal symptoms and quality of life in patients with chronic myocardial ischemia, International Journal of Cardiology 168(3): 3031-3032.
- Barkholt, L.; Flory, E.; Jekerle, V.; Lucas-Samuel, S.; Ahnert, P.; Bisset, L.; Buscher, D.; Fibbe, W.; Foussat, A.; Kwa, M.; Lantz, O.; Maciulaitis, R.; Palomaki, T.; Schneider, C.K.; Sensebe, L.; Tachdjian, G.; Tarte, K.; Tosca, L. & Salmikangas, P. (2013), Risk of tumorigenicity in mesenchymal stromal cell-based therapies-Bridging scientific observations and regulatory viewpoints, Cytotherapy 15(7): 753-759.
- Isern, J.; Martin-Antonio, B.; Ghazanfari, R.; Martin, A.M.; Lopez, J.A.; Toro, R. del; Sanchez-Aguilera, A.; Arranz, L.; Martin-Perez, D.; Suarez-Lledo, M.; Marin, P.; Pel, M. van; Fibbe, W.E.; Vazquez, J.; Scheding, S.; Urbano-Ispizua, A. & Mendez-Ferrer, S. (2013), Self-Renewing Human Bone Marrow Mesenspheres Promote Hematopoietic Stem Cell Expansion, Cell Reports 3(5): 1714-1724.
- Melief, S.M.; Zwaginga, J.J.; Fibbe, W.E. & Roelofs, H. (2013), Adipose Tissue-Derived Multipotent Stromal Cells Have a Higher Immunomodulatory Capacity Than Their Bone Marrow-Derived Counterparts, Stem Cells Translational Medicine 2(6): 455-463.
- Ball, L.M.; Bernardo, M.E.; Roelofs, H.; Tol, M.J.D. van; Contoli, B.; Zwaginga, J.J.; Avanzini, M.A.; Conforti, A.; Bertaina, A.; Giorgiani, G.; Jol-van der Zijde, C.M.; Zecca, M.; Blanc, K. le; Frassoni, F.; Egeler, R.M.; Fibbe, W.E.; Lankester, A.C. & Locatelli, F. (2013), Multiple infusions of mesenchymal stromal cells induce sustained remission in children with steroid-refractory, grade III-IV acute graft-versus-host disease, British Journal of Haematology 163(4): 501-509.
- Melief, S.M.; Geutskens, S.B.; Fibbe, W.E. & Roelofs, H. (2013), Multipotent stromal cells skew monocytes towards an anti-inflammatory interleukin-10-producing phenotype by production of interleukin-6, Haematologica 98(6): 888-895.
- Melief, S.M.; Geutskens, S.B.; Fibbe, W.E. & Roelofs, H. (2013), Multipotent stromal cells skew monocytes towards an anti-inflammatory function: the link with key immunoregulatory molecules, Haematologica 98(9): E121-E122.
- Staal, F.J.T. & Fibbe, W.E. (2012), Wnt cross-talk in the niche., Blood 119(7): 1618-9.
- Ramkisoensing, A.A.; Pijnappels, D.A.; Swildens, J.; Goumans, M.J.; Fibbe, W.E.; Schalij, M.J.; Vries, A.A.F. de & Atsma, D.E. (2012), Gap Junctional Coupling with Cardiomyocytes is Necessary but Not Sufficient for Cardiomyogenic Differentiation of Cocultured Human Mesenchymal Stem Cells, STEM CELLS 30(6): 1236-1245.
- Wit, T.D. de; Borkhardt, A.; Chomienne, C.; Dohner, H.; Fibbe, W.E.; Foa, R.; Hagenbeek, A.; Skoda, R.C.; Smand, C.R. & Jager, U. (2012), Raising hematology's European voice: the Importance of calling yourself a hematologist, Haematologica 97(4): 476-478.
- Haan, M.C. den; Grauss, R.W.; Smits, A.M.; Winter, E.M.; Tuyn, J. van; Pijnappels, D.A.; Steendijk, P.; Gittenberger-De Groot, A.C.; Laarse, A. van der; Fibbe, W.E.; Vries, A.A.F. de; Schalij, M.J.; Doevendans, P.A.; Goumans, M.J. & Atsma, D.E. (2012), Cardiomyogenic differentiation-independent improvement of cardiac function by human cardiomyocyte progenitor cell injection in ischaemic mouse hearts, Journal of Cellular and Molecular Medicine 16(7): 1508-1521.
- Melief, S.; Schrama, E.; Geutskens, S.; Tiemessen, M.; Hoogduijn, M.; Roelofs, H. & Fibbe, W. (2012), A CRUCIAL ROLE FOR MONOCYTES IN THE IMMUNOMODULATORY PROPERTIES OF MULTIPOTENT STROMAL CELLS, Experimental Hematology 40(8): S161-S161.
- Schipper, L.F.; Brand, A.; Fibbe, W.E. & Hensbergen, Y. van (2012), Functional Characterization of TPO-Expanded CD34(+) Cord Blood Cells Identifies CD34(-)CD61(-) Cells as Platelet-Producing Cells Early After Transplantation in NOD/SCID Mice and rCD34(+) Cells as CAFC Colony-Forming Cells, STEM CELLS 30(5): 988-996.
- Wiekmeijer, A.S.; Pike-Overzet, K.; Brugman, M.; Fibbe, W. & Staal, F. (2012), LMO2 PERTURBS HUMAN T CELL DEVELOPMENT IN VIVO BY TWO DIFFERENT MECHANISMS, Experimental Hematology 40(8): S146-S147.
- Rodrigo, S.F.; Ramshorst, J. van; Beeres, S.L.; Younis, I. al; Dibbets-Schneider, P.; Roos, A. de; Fibbe, W.E.; Zwaginga, J.J.; Schalij, M.J.; Bax, J.J. & Atsma, D.E. (2012), Intramyocardial injection of bone marrow mononuclear cells in chronic myocardial ischemia patients after previous placebo injection improves myocardial perfusion and anginal symptoms: An intra-patient comparison, American Heart Journal 164(5): 771-778.
- Pel, M. van; Slot, E. & Fibbe, W. (2012), DIFFERENTIAL HEMATOPOIETIC STEM CELL SUPPORT BY CLONAL POPULATIONS OF BONE-DERIVED MESENCHYMAL STROMAL CELLS, Experimental Hematology: Journal for Hematology, Stem Cell Biology and Transplantation 40(8): S94-S94.
- Rodrigo, S.; Ramshorst, J. van; Beeres, S.; Younis, I. al; Dibbets-Schneider, P.; Fibbe, W.; Zwaginga, J.J.; Wall, E. van der; Schalij, M.; Bax, J. & Atsma, D. (2012), INTRAMYOCARDIAL INJECTION OF BONE MARROW DERIVED, EX VIVO EXPANDED, MESENCHYMAL STEM CELLS IN ACUTE MYOCARDIAL INFARCTION PATIENTS IS SAFE AND IMPROVES MYOCARDIAL PERFUSION AT 3 YEARS FOLLOW UP, Journal of the American College of Cardiology 59(13): E478-E478.
- Roozen, P.; Luis, T.; Naber, B.; Haas, E. de; Bres-Vloermans, A.; Brugman, M.; Fibbe, W.; Fodde, R.; Goeman, J. & Staal, F. (2012), MECHANISMS UNDERLYING THE DOSE DEPENDENT EFFECTS OF CANONICAL WNT SIGNALLING IN HEMATOPOIETIC STEM CELLS, Experimental Hematology: Journal for Hematology, Stem Cell Biology and Transplantation 40(8): S92-S92.
- Lengerke, C.; Fibbe, W.E.; Dick, J.E.; Kanz, L.; Kanz, L.; Fibbe, W.E.; Lengerke, C. & Dick, J.E. (2012), Preface for Hematopoietic Stem Cells VIII, Annals of the New York Academy of Sciences 1266: VII-VII.
- Schipper, L.F.; Brand, A.; Fibbe, W.E. & Hensbergen, Y. van (2012), Functional characterization of TPO-expanded CD34+ cord blood cells identifies CD34- CD61- cells as platelet-producing cells early after transplantation in NOD/SCID mice and rCD34+ cells as CAFC colony-forming cells.
- Bernardo, M.E.; Fibbe, W.E.; Kanz, L.; Fibbe, W.E.; Lengerke, C. & Dick, J.E. (2012), Safety and efficacy of mesenchymal stromal cell therapy in autoimmune disorders, Annals of the New York Academy of Sciences 1266: 107-117.
- Fibbe, W. (2012), Mesenchymal Stromal Cells: A new Paradigm for Cellular Immune Modulation, Human Gene Therapy 23(10): A12-A13.
- Pel, M. van; Galarza, J.P.; Carlotti, F.; Rabelink, M.; Cramer, S.; Hoeben, R. & Fibbe, W. (2012), CONSTRUCT OPTIMIZATION ALLOWS LIVE IMAGING OF IFN-1 STIMULATED MSC BY BIOLUMINESCENCE IMAGING IN VIVO, Experimental Hematology 40(8): S160-S160.
- Dominique, F.; Laar, J. van; Sont, J.K.; Naraghi, K.; Marjanovic, Z.; Largero, J.; Schuerwegh, A.; Marijt, E.W.A.; Vonk, M.; Schattenberg, A.; Matucci, M.; Miniati, I.; Voskuyl, A.; Loosdrecht, A.A. van de; Daikeler, T.; Koetter, I.; Schmarlzing, M.; Martin, T.; Weiner, S.; Deligny, C.; Durand, J.M.; Emery, P.; Machold, K.P.; Sarrot-Reynauld, F.; Warnatz, K.; Adoue, D.; Constans, J.; Tony, H.P.; Papa, N. del; Fassas, A.; Himsel, A.; Launay, D.; Monaco, A. lo; Philippe, P.; Quere, I.; Rich, E.; Westhovens, R.; Griffiths, B.; Saccardi, R.; Hoogen, F.H. van den; Fibbe, W.E.; Socie, G.; Gratwohl, A. & Tyndall, A. (2012), Autologous Hematopoietic Stem Cell Transplantation Versus Intravenous Pulse Therapy Cyclophosphamide for Severe or Rapidly Progressive Systemic Sclerosis, the Astis Trial, Blood 120(21).
- Staal, F.J.T. & Fibbe, W.E. (2012), Wnt cross-talk in the niche, Blood 119(7): 1618-1619.
- Ball, L.M.; Bernardo, M.E.; Tol, M.J.D. van; Giorgiani, G.; Roelofs, H.; Cometa, A.M.; Bertaina, A.; Zwaginga, J.J.; Zijde, E.J. van de; Avanzini, M.A.; Blanc, K. le; Ringden, O.; Frassoni, F.; Fibbe, W.E.; Egeler, M.; Lankester, A.C. & Locatelli, F. (2011), Mesenchymal stromal cells are highly effective in steroid-refractory, grade III-IV acute graft-versus-host disease in children, Bone Marrow Transplantation 46: S6S7.
- Luis, T.C.; Naber, B.A.E.; Roozen, P.P.C.; Brugman, M.H.; Haas, E.F.E. de; Ghazvini, M.; Fibbe, W.E.; Dongen, J.J.M. van; Fodde, R. & Staal, F.J.T. (2011), Canonical Wnt Signaling Regulates Hematopoiesis in a Dosage-Dependent Fashion, Cell Stem Cell 9(4): 345-356.
- Duijvestein, M.; Wildenberg, M.E.; Welling, M.M.; Hennink, S.; Molendijk, I.; Zuylen, V.L. van; Bosse, T.; Vos, A.C.W.; Jonge-Muller, E.S.M. de; Roelofs, H.; Weerd, L. van der; Verspaget, H.W.; Fibbe, W.E.; Velde, A.A.T.; Brink, G.R. van den & Hommes, D.W. (2011), Pretreatment with Interferon-gamma Enhances the Therapeutic Activity of Mesenchymal Stromal Cells in Animal Models of Colitis, STEM CELLS 29(10): 1549-1558.
- Duijvestein, M.; Molendijk, I.; Roelofs, H.; Vos, A.C.W.; Verhaar, A.P.; Reinders, M.E.J.; Fibbe, W.E.; Verspaget, H.W.; Brink, G.R. van den; Wildenberg, M.E. & Hommes, D.W. (2011), Mesenchymal stromal cell function is not affected by drugs used in the treatment of inflammatory bowel disease, Cytotherapy 13(9): 1066-1073.
- Staal, F.J.T.; Baum, C.; Cowan, C.; Dzierzak, E.; Hacein-Bey-Abina, S.; Karlsson, S.; Lapidot, T.; Lemischka, I.; Mendez-Ferrer, S.; Mikkers, H.; Moore, K.; Moreno, E.; Mummery, C.L.; Robin, C.; Suda, T.; Pel, M. van; Brink, G.V.; Zwaginga, J.J. & Fibbe, W.E. (2011), Stem cell self-renewal: lessons from bone marrow, gut and iPS toward clinical applications, Leukemia 25(7): 1095-1102.
- Ramshorst, J. van; Antoni, M.L.; Beeres, S.L.M.A.; Roes, S.D.; Delgado, V.; Rodrigo, S.F.; Roos, A. de; Holman, E.R.; Fibbe, W.E.; Lamb, H.J.; Zwaginga, J.J.; Boersma, E.; Wall, E.E. van der; Schalij, M.J.; Atsma, D.E. & Bax, J.J. (2011), Intramyocardial Bone Marrow-Derived Mononuclear Cell Injection for Chronic Myocardial Ischemia The Effect on Diastolic Function, Circulation: Cardiovascular Imaging 4(2): 122-129.
- Hellingman, A.A.; Zwaginga, J.J.; Beem, R.T. van; Hamming, J.F.; Fibbe, W.E.; Quax, P.H.A.; Geutskens, S.B. & TeRM Smart Mix Consortium (2011), T-cell-pre-stimulated Monocytes Promote Neovascularisation in a Murine Hind Limb Ischaemia Model., European Journal of Vascular and Endovascular Surgery 41(3): 418-28.
- Bernardo, M.E.; Ball, L.M.; Cometa, A.M.; Roelofs, H.; Zecca, M.; Avanzini, M.A.; Bertaina, A.; Vinti, L.; Lankester, A.; Maccario, R.; Ringden, O.; Blanc, K. le; Egeler, R.M.; Fibbe, W.E. & Locatelli, F. (2011), Co-infusion of ex vivo-expanded, parental MSCs prevents life-threatening acute GVHD, but does not reduce the risk of graft failure in pediatric patients undergoing allogeneic umbilical cord blood transplantation, Bone Marrow Transplantation 46(2): 200-207.
- Luis, T.C.; Naber, B.A.E.; Roozen, P.P.C.; Brugman, M.H.; Haas, E.F.E. de; Ghazvini, M.; Fibbe, W.E.; Dongen, J.J.M. van; Fodde, R. & Staal, F.J.T. (2011), Canonical wnt signaling regulates hematopoiesis in a dosage-dependent fashion., Cell Stem Cell 9(4): 345-56.
- Westerhuis, G.; Pel, M. van; Toes, R.E.M.; Staal, F.J.T. & Fibbe, W.E. (2011), Chimerism levels after stem cell transplantation are primarily determined by the ratio of donor to host stem cells, Blood 117(16): 4400+.
- Fibbe, W.E. (2011), Preface.
- Hellingman, A.A.; Zwaginga, J.J.; Beem, R.T. van; Hamming, J.F.; Fibbe, W.E.; Quax, P.H.A.; Geutskens, S.B. & TeRM Smart Mix Consortium (2011), T-cell-pre-stimulated Monocytes Promote Neovascularisation in a Murine Hind Limb Ischaemia Model.
- Haan, M.C. den; Grauss, R.W.; Smits, A.M.; Winter, E.M.; Tuyn, J. van; Pijnappels, D.A.; Steendijk, P.; Gittenberger-De Groot, A.C.; Laarse, A. van der; Fibbe, W.E.; Vries, A.A.F. de; Schalij, M.J.; Doevendans, P.A.; Goumans, M.J. & Atsma, D.E. (2011), Cardiomyogenic differentiation-independent improvement of cardiac function by human cardiomyocyte progenitor cell injection in ischemic mouse hearts.
- Duijvestein, M.; Molendijk, I.; Roelofs, H.; Vos, A.C.W.; Verhaar, A.P.; Reinders, M.E.J.; Fibbe, W.E.; Verspaget, H.W.; Brink, G.R. van den; Wildenberg, M.E. & Hommes, D.W. (2011), Mesenchymal stromal cell function is not affected by drugs used in the treatment of inflammatory bowel disease., Cytotherapy 13(9): 1066-73.
- Ramshorst, J. van; Antoni, M.L.; Beeres, S.L.M.A.; Roes, S.D.; Delgado, V.; Rodrigo, S.F.; Roos, A. de; Holman, E.R.; Fibbe, W.E.; Lamb, H.J.; Zwaginga, J.J.; Boersma, E.; Wall, E.E. van der; Schalij, M.J.; Atsma, D.E. & Bax, J.J. (2011), Intramyocardial Bone Marrow-Derived Mononuclear Cell Injection for Chronic Myocardial Ischemia: the Effect on Diastolic Function., Circulation: Cardiovascular Imaging.
- Staal, F.J.T.; Baum, C.; Cowan, C.; Dzierzak, E.; Hacein-Bey-Abina, S.; Karlsson, S.; Lapidot, T.; Lemischka, I.; Mendez-Ferrer, S.; Mikkers, H.; Moore, K.; Moreno, E.; Mummery, C.L.; Robin, C.; Suda, T.; Pel, M. van; Brink, G.V.; Zwaginga, J.J. & Fibbe, W.E. (2011), Stem cell self-renewal: lessons from bone marrow, gut and iPS toward clinical applications., Leukemia 25(7): 1095-102.
- Fibbe, W.E. (2011), Introduction: mesenchymal stromal cells (MSCs)., Best Practice and Research: Clinical Haematology 24(1): 1-2.
- Ball, L.M.; Bernardo, M.E.; Tol, M.J.D. van; Roelofs, H.; Zwaginga, J.J.; Locatelli, F.; Fibbe, W.E. & Egeler, R.M. (2010), Multiple infusions of haploidentical mesenchymal stromal cells are not immunogenic in children undergoing myeloablative stem cell transplantation, Bone Marrow Transplantation 45: S382S382.
- Ball, L.M.; Bernardo, M.E.; Tol, M.J.D. van; Avanzini, M.A.; Lankester, A.C.; Roelofs, H.; Giorgiani, G.; Zwaginga, J.J.; Blanc, K. le; Fibbe, W.E.; Egeler, R.M. & Locatelli, F. (2010), Children responding to treatment with mesenchymal stromal cells for refractory severe graft-versus-host disease have excellent long-term outcome, Bone Marrow Transplantation 45: S261S261.
- Reinders, M.E.J.; Fibbe, W.E. & Rabelink, T.J. (2010), Multipotent mesenchymal stromal cell therapy in renal disease and kidney transplantation, Nephrology Dialysis Transplantation 25(1): 17-24.
- Ball, L.M.; Bernardo, M.E.; Tol, M.J.D. van; Avanzini, M.A.; Lankester, A.C.; Roelofs, H.; Giorgiani, G.; Zwaginga, J.J.; Blanc, K. le; Fibbe, W.E.; Egeler, R.M. & Locatelli, F. (2010), Children responding to treatment with mesenchymal stromal cells for refractory severe graft-versus-host disease have excellent long-term outcome, Bone Marrow Transplantation 45: S261S261.
- Ball, L.M.; Bernardo, M.E.; Zwaginga, J.J.; Tol, M. van; Cometa, A.; Roelofs, H.; Giorgiani, G.; Jol-van der Zijde, C.M.; Avanzini, M.A.; Blanc, K. le; Bertaina, A.; Frassoni, F.; Fibbe, W.E.; Ringden, O.; Egeler, R.M.; Locatelli, F. & Lankester, A. (2010), Early Intervention with Mesenchymal Stromal Cells for Refractory Grade III-IV Graft Versus Host Disease In Children Results In Excellent Long Term Outcome., Blood 116(21): 965-965.
- Kruijf, E.J.F.M. de; Hagoort, H.; Velders, G.A.; Fibbe, W.E. & Pel, M. van (2010), Hematopoietic stem and progenitor cells are differentially mobilized depending on the duration of Flt3-ligand administration, Haematologica 95(7): 1061-1067.
- Prockop, D.J.; Brenner, M.; Fibbe, W.E.; Horwitz, E.; Blanc, K. le; Phinney, D.G.; Simmons, P.J.; Sensebe, L. & Keating, A. (2010), Defining the risks of mesenchymal stromal cell therapy, Cytotherapy 12(5): 576-578.
- Li, S.; Starckx, S.; Martens, E.; Dillen, C.; Lamerant-Fayel, N.; Berghmans, N.; Gouwy, M.; Pel, M. van; Heremans, H.; Kieda, C.; Fibbe, W.E.; Billiau, A.; Damme, J. van & Opdenakker, G. (2010), Myeloid cells are tunable by a polyanionic polysaccharide derivative and co-determine host rescue from lethal virus infection, Journal of Leukocyte Biology 88(5): 1017-1029.
- Luis, T.C.; Naber, B.A.E.; Fibbe, W.E.; Dongen, J.J.M. van & Staal, F.J.T. (2010), Wnt3a nonredundantly controls hematopoietic stem cell function and its deficiency results in complete absence of canonical Wnt signaling, Blood 116(3): 496-497.
- Ball, L.M.; Schweizer, J.; Lankester, A.; Bernardo, M.E.; Tol, M.J.D. van; Roelofs, H.; Zwaginga, J.J.; Fibbe, W.E.; Locatelli, F. & Egeler, R.M. (2010), Gastrointestinal steroid refractory GvHD in children successfully treated with mesenchymal stromal cells cannot be solely assessed by clinical response, Bone Marrow Transplantation 45: S132S133.
- Pel, M. van; Monge, M.; Siebelt, M.; Aleksinskaya, M.M.; Boer, H.C. de; Duijs, J.; Solingen, C. van; Massy, Z.; Rabelink, T.J.; Fibbe, W.E. & Zonneveld, A.J. van (2010), Chronic Kidney Disease Induces a Reduction In Hematopoietic Stem -and Progenitor Cell Frequencies, Blood 116(21): 1577-1578.
- Duijvestein, M.; Vos, A.C.W.; Roelofs, H.; Wildenberg, M.E.; Wendrich, B.B.; Verspaget, H.W.; Kooy-Winkelaar, E.M.C.; Koning, F.; Zwaginga, J.J.; Fidder, H.H.; Verhaar, A.P.; Fibbe, W.E.; Brink, G.R. van den & Hommes, D.W. (2010), Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study, Gut 59(12): 1662-1669.
- Avanzini MA, Bernardo ME, Cometa AM, Perotti C, Zaffaroni N, Novara F, Visai L, Moretta A, Del Fante C & Villa R (2009), Generation of mesenchymal stromal cells in the presence of platelet lysate: a phenotypic and functional comparison of umbilical cord blood- and bone marrow-derived progenitors, Haematologica 94(12): 1649-1660.
- van Ramshorst J, Bax JJ, Beeres SLMA, Dibbets-Schneider P, Roes SD, Stokkel MPM, de Roos A, Fibbe WE, Zwaginga JJ, Boersma E, Schalij MJ & Atsma DE (2009), Intramyocardial Bone Marrow Cell Injection for Chronic Myocardial Ischemia A Randomized Controlled Trial, Journal of the American Medical Association 301(19): 1997-2004.
- Cupedo T, Crellin NK, Papazian N, Rombouts EJ, Weijer K, Grogan JL, Fibbe WE, Cornelissen JJ & Spits H (2009), Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+ CD127(+) natural killer-like cells, Nature Immunology 10(1): 66-74.
- Roelen DL, van der Mast BJ, in't Anker PS, Kleijburg C, Eikmans M, van Beelen E, de Groot-Swings GM, Fibbe WE, Kanhai HH, Scherjon SA & Claas FH (2009), Differential immunomodulatory effects of fetal versus maternal multipotent stromal cells., Human Immunology 70(1): 16-23.
- Kuiperij HB, van Pel M, de Rooij KE, Hoeben RC & Fibbe WE (2009), Serpinal (alpha 1-AT) is synthesized in the osteoblastic stem cell niche.
- de Jager SCA, Cante-Barrett K, Bot I, Husberg C, van Puijvelde GH, van Santbrink PJ, Yndestad A, van den Oever JME, Kuiper J & van Berkel TJC (2009), Impaired Effector Memory T-Cell Regulation Facilitates Graft Versus Host Disease in CCR7-Deficient Bone Marrow Transplant Chimeras, Transplantation 88(5): 631-639.
- de Jager SC, Canté-Barrett K, Bot I, Husberg C, van Puijvelde GH, van Santbrink PJ, Yndestad A, van den Oever JM, Kuiper J, van Berkel TJ, Lipp M, Zwaginga JJ, Fibbe WE, Aukrust P & Biessen EA (2009), Impaired effector memory T-cell regulation facilitates graft versus host disease in CCR7-deficient bone marrow transplant chimeras.
- van Ramshorst J, Bax JJ, Beeres SL, Dibbets-Schneider P, Roes SD, Stokkel MP, de Roos A, Fibbe WE, Zwaginga JJ, Boersma E, Schalij MJ & Atsma DE (2009), Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial., Journal of the American Medical Association 301(19): 1997-2004.
- Wiersum-Osselton J, van Walraven AM, Fibbe W & Brand A (2009), Retrospective study of safety of peripheral blood stem cell donation by family members, Bone Marrow Transplantation 43: S293S293.
- Westerhuis G, Maas WG, Toes RE & Fibbe WE (2009), Persisting NK cell alloreactivity in the presence of long-term stable hematopoietic chimerism.
- von dem Borne PA, Starrenburg CW, Halkes SJ, Marijt WA, Fibbe WE, Falkenburg JH & Willemze R (2009), Reduced-intensity conditioning allogeneic stem cell transplantation with donor T-cell depletion using alemtuzumab added to the graft ('Campath in the bag')., Current Opinion in Oncology 21 Suppl 1: S27-9.
- Kuiperij HB, van Pel M, de Rooij KE, Hoeben RC & Fibbe WE (2009), Serpina1 (alpha1-AT) is synthesized in the osteoblastic stem cell niche.
- Bernardo M, Avanzini M, Perotti C, Cometa A, Zaffaroni N, Novara F, Moretta A, Maccario R, Fibbe W & Locatelli F (2009), Immunomodulatory properties of umbilical cord blood-derived mesenchymal stromal cells expanded in the presence of platelet lysate: potential for clinical application, Bone Marrow Transplantation 43: S160S160.
- Westerhuis G, Maas WGE, Toes REM & Fibbe WE (2009), Persisting NK cell alloreactivity in the presence of long-term stable hematopoietic chimerism, Experimental Hematology 37(6): 739-743.
- Roelen, D.L.; Mast, B.J. van der; Anker, P.S.I.; Kleijburg, C.; Eikmans, M.; Beelen, E. van; Groot-Swings, G.M.J.S. de; Fibbe, W.E.; Kanhai, H.H.H.; Scherjon, S.A. & Claas, F.H.J. (2009), Differential immunomodulatory effects of fetal versus maternal multipotent stromal cells, Human Immunology 70(1): 16-23.
- Weisel KC, Dick J, Fibbe WE & Kanz L (2009), International Symposium and Workshop on Hematopoietic Stem Cells VII, University of Tubingen, Germany, September 18-20, 2008, Annals of the New York Academy of Sciences 1176: 1-17.
- Battula VL, Treml S, Bareiss PM, Gieseke F, Roelofs H, de Zwart P, Muller I, Schewe B, Skutella T & Fibbe WE (2009), Isolation of functionally distinct mesenchymal stem cell subsets using antibodies against CD56, CD271, and mesenchymal stem cell antigen-1, Haematologica 94(2): 173-184.
- Engelse MA, Loomans CJ, Oostendorp J, Ringers J, van Rossenberg EH, Steeneveld E, Overdevest JJ, Guchelaar HJ, van Bockel JH, Romijn HA, Fibbe WE, Zwaginga JJ, Rabelink TJ & de Koning EJ (2009), Initiation of a islet isolation program in The Netherlands, Xenotransplantation 16(5): 398-398.
- Bernardo ME, Locatelli F & Fibbe WE (2009), Mesenchymal Stromal Cells A Novel Treatment Modality for Tissue Repair, Annals of the New York Academy of Sciences 1176: 101-117.
- Fibbe WE (2009), Mesenchymal stem cell therapy, a cellular form of immune suppression?, Human Gene Therapy 20(11): 1365-1365.
- Migliaccio AR, Martelli F, Verrucci M, Sanchez M, Valeri M, Migliaccio G, Vannucchi AM, Zingariello M, Di Baldassarre A & Ghinassi B (2009), Gata1 expression driven by the alternative HS2 enhancer in the spleen rescues the hematopoietic failure induced by the hypomorphic Gata1(low) mutation, Blood 114(10): 2107-2120.
- Le Blanc K & Fibbe W (2008), A new cell therapy registry coordinated by the European Group for Blood and Marrow Transplantation (EBMT), Bone Marrow Transplantation 41(3).
- van Pel M, Hagoort H, Kwakkenbos MJ, Hamann J & Fibbe WE (2008), Differential role of CD97 in interleukin-8-induced and granulocyte-colony stimulating factor-induced hematopoietic stem and progenitor cell mobilization, Haematologica 93(4).
- Marijt W, Baas I, von dem Borne P, Barge R, Deutz P, Beaumont F, Starrenburg I, Fibbe W, Willemze R & Falkenburg J (2008), Prevention of relapse by donor lymphocyte infusion for mixed chimerism 7 months after T-cell depleted allogeneic stem cell transplantation, Bone Marrow Transplantation 41.
- van Pel M, Hagoort H, Hamann J & Fibbe WE (2008), CD97 is differentially expressed on murine hematopoietic stem- and progenitor-cells, Haematologica 93(8).
- Le Blanc K, Fibbe W, Frassoni F, Locatelli F & Ringden O (2008), Mesenchymal stem cells for acute graft-versus-host disease - Reply, Lancet 372(9640).
- LeBlanc K, Frassoni F, Ball L, Locatelli F, Roelofs H, Lewis I, Lanino E, Sundberg B, Bernardo ME, Remberger M, Dini G, Egeler RM, Bacigalupo A, Fibbe W & Ringden O (2008), Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study, Lancet 371(9624).
- Braakman E, Schuurhuis GJ, Preijers FWMB, Voermans C, Theunissen K, van Riet I, Fibbe WE & Slaper-Cortenbach I (2008), Evaluation of 'out-of-specification' CliniMACS CD34-selection procedures of hematopoietic progenitor cell-apheresis products, Cytotherapy 10(1).
- Vellenga E, van Putten WLJ, van't Veer MB, Zijlstra JM, Fibbe WE, van Oers MHJ, Verdonck LF, Wijermans PW, van Imhoff GW, Lugtenburg PJ & Huijgens PC (2008), Rituximab improves the treatment results of DHAP-VIM-DHAP and ASCT in relapsed/progressive aggressive CD20(+) NHL: a prospective randomized HOVON trial, Blood 111(2).
- Vonk MC, Marjanovic Z, van den Hoogen FHJ, Zohar S, Schattenberg AVMB, Fibbe WE, Larghero J, Gluckman E, van Laar JM, Farge D, Preijers FWMB, van Dijk APJ, Bax JJ, Roblot P & van Riel PLCM (2008), Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis, Annals of the Rheumatic Diseases 67(1).
- Ball L, Bredius R, Lankester A, Schweizer J, van den Heuvel-Eibrink M, Escher H, Fibbe W & Egeler M (2008), Third party mesenchymal stromal cell infusions fail to induce tissue repair despite successful control of severe grade IV acute graft-versus-host disease in a child with juvenile myelo-monocytic leukemia, Leukemia 22(6).
- Brand A, Rebulla P, Engelfriet CP, Reesink HW, Beguin Y, Baudoux E, Kogler G, Ebrahimi M, Grazzini G, Costa AN, Bosi A, Sacchi N, Lombardini L, Pupella S, Lecchi L, Garciduenas EDC, van Beckhoven JM, de Wit HJC, Fibbe WE, Zhiburt EB, Bart T, Beksac M, Navarrete C & Regan F (2008), Cord blood banking, Vox Sanguinis 95(4).
- Beeres SLMA, Lamb HJ, Roes SD, Holman ER, Kaandorp TAM, Fibbe WE, de Roos A, van der Wall EE, Schalij MJ, Bax JJ & Atsma DE (2008), Effect of intramyocardial bone marrow cell injection on diastolic function in patients with chronic myocardial ischemia, Journal of Magnetic Resonance Imaging 27(5).
- Tongeren R, Hamming JF, Fibbe WE, Van Weel V, Frerichs SJGC, Stiggelbout AM, Van Bockel JH & Lindeman JH (2008), Intramuscular or combined intramuscular/intra-arterial administration of bone marrow mononuclear cells: a clinical trial in patients with advanced limb ischemia, Journal of Cardiovascular Surgery 49(1).
- Ball LM, Bernardo ME, Roelofs H, Lankester A, Cometa A, Egeler RM, Cometa A, Giorgiani G, Locatelli F & Fibbe WE (2007), Co-transplantation of HLA-haploidentical, bone mat-row derived mesenchymal stem cells prevents graft failure and improves hematological recovery in T-cell depleted haploidentical stem cell transplantation, Blood 110(11).
- Tolar, J.; Nauta, A.J.; Osborn, M.J.; Mortari, A.P.; McElmurry, R.T.; Bell, S.; Xia, L.L.; Zhou, N.; Riddle, M.; Schroeder, T.M.; Westendorf, J.J.; McIvor, R.S.; Hogendoorn, P.C.W.; Szuhai, K.; Oseth, L.; Hirsch, B.; Yant, S.R.; Kay, M.A.; Peister, A.; Prockop, D.J.; Fibbe, W.E. & Blazar, B.R. (2007), Sarcoma derived from cultured mesenchymal stem cells, Stem Cells 25(2).
- Bernardo ME, Ball L, Cometa A, Zecca M, Giorgiani G, Maccario R, Barberi W, Comoli P, Bonetti F, Le Blanc K, Roelofs H, Egeler M, Fibbe W & Locatelli F (2007), Co-transplantation of parental mesenchymal stem cells to improve outcome of cord blood transplantation in children, Bone Marrow Transplantation 39.
- Filerman R, Westerhuis G, Hameetman M, van Dulvenvoorde LM, van Hall T, van Lear JM, Fibbe WE & Toes REM (2007), Targeting host B-cell immune responses by persistent donor NK-cell alloreactivity following nonmyeloablative allogeneic stem cell transplantation, Blood 109(12).
- Atsma DE, Fibbe WE & Rabelink TJ (2007), Opportunities and challenges for mesenchymal stem cell-mediated heart repair, Current Opinion in Lipidology 18(6).
- Bernardo ME, Emons JAM, Karperien M, Nauta AJ, Willemze R, Roelofs H, Romeo S, Marchini A, Rappold GA, Vukicevic S, Locatelli F & Fibbe WE (2007), Human mesenchymal stem cells derived from bone marrow display a better chondrogenic differentiation compared with other sources, Connective Tissue Research 48(3).
- Weisel KC, Fibbe WE & Kanz L (2007), Meeting summary: International symposium and workshop on hematopoietic stem cells VI, University of Tubingen, Germany, September 14-16, 2006, Experimental Hematology 35(7).
- Ball LM, Kollen WJW, Bernado ME, Lankester A, Roelofs H, Locatelli F, Fibbe WE & Egeler RM (2007), Co-transplanation of haploidentical mesenchymal stem cells to overcome graft dysfunction associated with parental haploidentical CD34 postive selected peripheral stem cell grafts, Biology of Blood and Marrow Transplantation 13(2).
- Schipper LF, van Hensbergen Y, Fibbe WE & Brand A (2007), A sensitive quantitative single-platform flow cytometry protocol to measure human platelets in mouse peripheral blood, Transfusion 47(12).
- Beeres SLMA, Bax JJ, Dibbets-Schneider P, Stokkel MPM, Fibbe WE, van der Wall EE, Schalij MJ & Atsma DE (2007), Intramyocardial injection of autologous bone marrow mononuclear cells in patients with chronic myocardial infarction and severe left ventricular dysfunction, American Journal of Cardiology 100(7).
- Ball LM, Bernardo ME, Roelofs H, Lankester A, Cometa A, Egeler RM, Locatelli F & Fibbe WE (2007), Cotransplantation of ex vivo-expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation, Blood 110(7).
- Beeres SLMA, Bax JJ, Zeppenfeld K, Dibbets-Schneider P, Stokkel MPM, Fibbe WE, van der Wall EE, Schalij MJ & Atsma DE (2007), Feasibility of trans-endocardial cell transplantation in chronic ischaemia, Heart 93(1).
- Fibbe WE, Nauta AJ & Roelofs H (2007), Modulation of immune responses by mesenchymal stem cells, Annals of the New York Academy of Sciences 1106.
- Beeres SLMA, Zeppenfeld K, Bax JJ, Dibbets-Schneider P, Stokkel MPM, Fibbe WE, van der Wall EE, Atsma DE & Schalij MJ (2007), Etectrophysiological and arrhythmogenic effects of intramyocardial bone marrow cell injection in patients with chronic ischemic heart disease, Heart Rhythm 4(3).
- Tyndall A, Walker UA, Cope A, Dazzi F, De Bari C, Fibbe W, Guiducci S, Jones S, Jorgensen C, Le Blanc K, Luyten F, McGonagle D, Martin I, Bocelli-Tyndall C, Pennesi G, Pistoia V, Pitzalis C, Uccelli A, Wulffraat N & Feldmann M (2007), Immunomodulatory properties of mesenchymal stem cells: a review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 October 2005, Arthritis Research and Therapy 9(1).
- de Kruijf EJFM, van Pel M, Hagoort H, Kruysdijk D, Molineux G, Willemze R & Fibbe WE (2007), Repeated hematopoietic stem and progenitor cell mobilization without depletion of the bone marrow stem and progenitor cell pool in mice after repeated administration of recombinant murine G-CSF, Human Immunology 68(5).
- Tan SS, Groota CAUD, Huijgens PC & Fibbe WE (2007), Stem cell transplantation in Europe: Trends and prospects, European Journal of Cancer 43(16).
- Walraven AM, Bernardo ME, Brand A, Roelofs H, Locatelli F, Egeler RM, Fibbe WE & Ball LM (2007), Parents' commitment to participation in mesenchymal stem cell donation and research demonstrates extensive altruism to other patients, Blood 110(11).
- Nauta AJ & Fibbe WE (2007), Hnmunomodulatory properties of mesenchymal stromal cells, Blood 110(10).
- van Walraven SM, Bernardo ME, Brand A, Roelofs H, Locatelli F, Egeler RM, Fibbe WE & Ball LM (2007), Means to an end - parents' commitment to participation in mesenchymal stem cell donation, Bone Marrow Transplantation 39.
- Beere SLMA, Lamb HJ, Roes SD, van Ramshorst J, Holman ER, Kaandorp TAM, Fibbe WE, de Roos A, van der Wall EE, Schalij MJ, Bax JJ & Atsma DE (2007), Effect of intramyocardial bone marrow cell injection on diastolic function in patients with chronic myocardial ischemia, Journal of the American College of Cardiology 49(9).
- Beeres SLMA, Bax JJ, van Ramshorst J, Dibbets-Schneider P, Stokkel MPM, Fibbe WE, van der Wall EE, Schalij MJ & Atsma DE (2007), Intramyocardial injection of autologous bone marrow mononuclear cells in patients with severe postinfarction heart failure is safe, reduces heart failure symptoms, improves exercise capacity and increases left ventricular function, Journal of the American College of Cardiology 49(9).
- Ball LM, Kollen WJW, Lankester A, Roleofs H, Fibbe WE & Egeler RM (2007), Treatment of steroid refractory, severe acute graft versus host disease with expanded mesenchymal stem cells in children having undergone allogeneic stem cell transplant tion: A single center experience, Biology of Blood and Marrow Transplantation 13(2).
- Ball LM, LeBlanc K, Roelofs H, Lankester AC, Egeler M, Frassoni F, Ringden O & Fibbe WE (2006), Co-transplantation of haplo-identical bone marrow-derived mesenchymal stem cells and hematopoietic stem cells to promote engraftment in children. A phase I/II multicenter study., Cytotherapy 8.
- Borghans JA, Bredius RG, Hazenberg MD, Roelofs H, Zijde ECJVD, Heidt J, Otto SA, Kuijpers TW, Fibbe WE, Vossen JM, Miedema F & van Tol MJ (2006), Early determinants of long-term T-cell reconstitution after hematopoietic stem cell transplantation for severe combined immunodeficiency, Blood 108(2).
- Tolar, J.; Nauta, A.J.; Osborn, M.J.; Panoskaltsis-Mortari, A.; McElmurry, R.T.; Bell, S.; Xia, L.; Zhou, N.; Riddle, M.; Schroeder, T.M.; Westendorf, J.J.; McIvor, R.S.; Hogendoom, P.C.W.; Szuhai, K.; Oseth, L.; Hirsch, B.; Yant, S.R.; Kay, M.A.; Peister, A.; Prockop, D.J.; Fibbe, W.E. & Blazar, B.R. (2006), Osteosarcoma derived from cultured mesenchymal stem cells., Blood 108(11).
- Beeres SLMA, Bax JJ, Zeppenfeld K, Stokkel MPM, Fibbe WE, Van der Wall E, Schalij MJ & Atsma DE (2006), Sustained effect of autologous bone marrow cell transplantation in no-option patients with chronic angina pectoris and myocardial ischemia: final 12 months results, European Heart Journal 27.
- van Pel M, van Os R, Velders GA, Hagoort H, Heegaard PMH, Lindley IJD, Willemze R & Fibbe WE (2006), Serpina1 is a potent inhibitor of IL-8-induced hematopoietic stem cell mobilization, Proceedings of the National Academy of Sciences 103(5).
- Ball LM, Le Blanc K, Roelofs H, Lankester A, Egeler RM, Frassoni F, Ringden O & Fibbe WE (2006), Co-transplantation of haploidentical bone marrow-derived mesenchymal stem cells and haematopoietic stem cells to promote engraftment in children. A phase I/II multicentre study, Bone Marrow Transplantation 37.
- Barge RMY, Starrenburg CWJ, Falkenburg JHF, Fibbe WE, Marijt EW & Willemze R (2006), Long-term follow-up of myeloablative allogeneic stem cell transplantation using Campath 'in the bag' as T-cell depletion: the Leiden experience, Bone Marrow Transplantation 37(12).
- Vonk MC, Marjanovic Z, van den Hoogen FH, Zohar S, Schattenberg AVMB, Fibbe WE, van Riel PLCM, van Laar JM & Farge D (2006), Long-term follow-up results after autologous hematopoietic stem cell transplantation for severe systemic sclerosis., Arthritis and Rheumatism 54(9).
- Beeres SLMA, Bax JJ, Kaandorp TAM, Zeppenfeld K, Lamb HJ, Dibbets P, Stokkel MP, de Roos A, Fibbe WE, van der Wall EE, Schalij MJ & Atsma DE (2006), Effect of autologous bone marrow-derived mononuclear cell injection on myocardial function and perfusion in patients with refractory angina pectoris and chronic ischemia, Journal of the American College of Cardiology 47(4).
- Flierman R, Westerhuis G, Fibbe W, Van Laar J & Toes R (2006), Alloreactive NK cells in the control of systemic autoimmune disease after allogeneic bone marrow transplantation, Annals of the Rheumatic Diseases 65.
- Vonk MC, Marjanovic Z, Van Laar JM, Schattenberg AVN, Fibbe WE, Van Riel PLCM, Van den Hoogen FHJ & Farge D (2006), Autologous hematopoietic stem cell transplantation in the treatment of systemic sclerosis: Follow-up results from an international phase I-II study, Annals of the Rheumatic Diseases 65.
- Beeres SLMA, Bax JJ, Zeppenfeld K, Fibbe WE, Van der Wall EE, Schalij MJ, Atsma DE & Stokkel MPM (2006), Sustained effect of atuologous bone marrow cell transplantation in no-option patients with severe angina pectoris and myocardial ischemia: 12 months results, European Journal of Nuclear Medicine and Molecular Imaging 33.
- Beeres SLMA, Bax JJ, Dibbets-Schneider P, Stokkel MPM, Fibbe WE, van der Wall EE, Schalij MJ & Atsma DE (2006), Sustained effect of autologous bone marrow mononuclear cell injection in patients with refractory angina pectoris and chronic myocardial ischemia: Twelve-month follow-up results, American Heart Journal 152(4).
- Nauta AJ, Westerhuis G, Kruisselbrink AB, Lurvink EGA, Willemze R & Fibbe WE (2006), Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting, Blood 108(6).
- Marijt EWA, Borne PAVD, Barge RMY, Deutz PP, Beaumont MF, Starrenburg CWJI, Fibbe WE, Willemze R & Falkenburg JHF (2006), Donor lymphocyte infusion (DLI) for mixed chimerism 6 months after T cell depleted allogeneic stem cell transplantation (TCD alloSCT) may prevent relapse., Blood 108(11).
- Beeres SLMA, Bax JJ, Kaandorp TAM, Zeppenfeld K, Lamb HJ, Dibbets-Schneider P, Stokkel MPM, Fibbe WE, de Roos A, van der Wall EE, Schalij MJ & Atsma DE (2006), Usefulness of intramyocardial injection of autologous bone marrow-derived mononuclear cells in patients with severe angina pectoris and stress-induced myocardial ischemia, American Journal of Cardiology 97(9).
- Beeres SLMA, Bax JJ, Dibbets P, Stokkel MPM, Zeppenfeld K, Fibbe WE, van der Wall EE, Schalij MJ & Atsma DE (2006), Effect of intramyocardial injection of autologous bone marrow-derived mononuclear cells on perfusion, function, and viability in patients with drug-refractory chronic ischemia, Journal of Nuclear Medicine 47(4).
- Dibbets-Schneider P, Beeres SLMA, Bax JJ, Kaandorp DAM, Lamb HJ, Fibbe WE, de Roos A, van der Wall EE, Schalij MJ, Atsma DE & Stokkel MPM (2006), Effect of intramyocardial injection of bone marrow-derived stem cells on myocardial function, perfusion an scar tissue in patients with drug-refractory chronic ischemia., European Journal of Nuclear Medicine and Molecular Imaging 33.
- Vonk MC, Marjanovic Z, van Laar JM, Schattenberg AVN, Fibbe WE, van Riel PLCM, Ertault M, Zohar S, & Farge D (2006), Autologous haematopoietic stem cell transplantation in severe systemic sclerosis: long-term results from three Dutch/French centres, Bone Marrow Transplantation 37.
- Nauta AJ, Kruisselbrink AB, Lurvink E, Willemze R & Fibbe WE (2006), Mesenchymal stem cells inhibit generation and function of both CD34(+)-derived and monocyte-derived dendritic cells, Journal of Immunology 177(4).
- van Velzen-Ball LM, Bernado ME, Locatelli F, Roelofs H, Lankester A, Maarten Egeler R & Fibbe WE (2006), Co-transplantation of haploidentical bone marrow derived mesenchymal stem cells overcomes graft dysfunction and improves hernatological and lymphocyte recovery in haploidentical stem cell transplantation., Blood 108(11).
- von dem Borne PA, Beaumont F, Starrenburg CWJI, Oudshoorn M, Hale G, Falkenburg JHF, Fibbe WE, Willemze R & Barge RMY (2006), Outcomes after myeloablative unrelated donor stem cell transplantation using both in vitro and in vivo T-cell depletion with alemtuzumab, Haematologica 91(11).
- Ringden O, Frassoni F, Uzunel M, Lanino E, Sundberg B, Lonnies H, Dini G, Bacigalupo A, Locatelli F, Fibbe W & Le Blanc K (2006), Mesenchymal stem cells for treatment of severe acute and extensive chronic graft-versus-host disease, Bone Marrow Transplantation 37.
- van Hensbergen Y, Schipper LF, Brand A, Slot MC, Welling M, Nauta AJ & Fibbe WE (2006), Ex vivo culture of human CD34(+) cord blood cells with thrombopoietin (TPO) accelerates platelet engraftment in a NOD/SCID mouse model, Experimental Hematology 34(7).
- Ball LM, Lankester AC, Roelofs H, Egeler RM & Fibbe WE (2005), Successful co-transplantation of haplo-identical bone marrow-derived mesenchymal stem cells and cytokine-mobilised peripheral blood stem cells, Bone Marrow Transplantation 35.
- Westerhuis G, Maas WGE, Willemze R, Toes REM & Fibbe WE (2005), Long-term mixed chimerism after immunologic conditioning and MHC-mismatched stem-cell transplantation is dependent on NK-cell tolerance, Blood 106(6).
- Beeres SL, Atsma DE, Zeppenfeld K, van der Laarse A, van den Bergh L, Fibbe WE, van der Wall EE, Bax J & Schalij MJ (2005), Intramyocardial injection of autologous bone marrow-derived mononuclear cells in no-option patients with chronic ischemia reduces anginal symptoms, improves left ventricular ejection fraction and increases myocardial perfusion, Circulation 112(17).
- Roelen DL, In't Anker ES, Van Beelen E, Kleyburg C, De Groot-Swings G, Van Schip JJ, Fibbe WE, Kanhai HHH, Scherjon SA & Claas FHJ (2005), The immunomodulatory effect of mesenchymal stem cells derived from the feto-maternal interface, American Journal of Transplantation 5.
- van Oosterhout M, Verburg RJ, Levarht EWN, Moolenburgh JD, Barge RM, Fibbe WE & van Laar JM (2005), High dose chemotherapy and syngeneic stem cell transplantation in a patient with refractory rheumatoid arthritis: poor response associated with persistence of host autoantibodies and synovial abnormalities, Annals of the Rheumatic Diseases 64(12).
- Velders GA & Fibbe WE (2005), Involvement of proteases in cytokine-induced hematopoietic stem cell mobilization, Annals of the New York Academy of Sciences 1044.
- Le Blanc K, Frassoni F, Ball L, Uzunel M, Lanini E, Sundberg B, Lonnies H, Dini G, Bacigalupo A, Locatelli F, Fibbe WE & Ringden OTH (2005), Mesenchymal stem cells for treatment of severe acute and extensive chronic graft-versus-host disease., Blood 106(11).
- Barge RMY, Hoogendoorn M, Marijt EWA, Beaumont F, Starrenburg I, Smit W, Posthuma W, Fibbe WE, Falkenburg F & Willemze R (2005), A two step nonmyeloablative allogeneic transplantation protocol using in vitro T-cell depleted mobilized stem cells followed by donor lymphocyte infusions in patients with advanced CLL., Blood 106(11).
- Beeres SLMA, Zeppenfeld K, Bax JJ, van der Laarse A, Fibbe WE, van der Wall EE, Schalij MJ & Atsma DE (2005), Intramyocardial injection of autologous bone marrow mononuclear cells in no-option patients with chronic ischaemia is safe, increases quality of life and improves left ventricular ejection fraction, European Heart Journal 26.
- Flierman R, Witteveen HJ, van der Voort EIH, Huizinga TWJ, de Vries RRP, Fibbe WE, Toes REM & van Laar JM (2005), Control of systemic B cell-mediated autoimmune disease by nonmyeloablative conditioning and major histocompatibility complex-mismatched allogeneic bone marrow transplantation, Blood 105(7).
- Fibbe WE (2005), Telomerase mutations in aplastic anemia, New England Journal of Medicine 352(14).
- Ball LM, Lankester AC, Bredius RGM, Fibbe WE, van Tol MJD & Egeler RM (2005), Graft dysfunction and delayed immune reconstitution following haploidentical peripheral blood hematopoietic stem cell transplantation, Bone Marrow Transplantation 35.
- Von dem Borne PA, Beaumont F, Starrenburg I, Oudshoom MA, Hale G, Falkenburg JHF, Fibbe WE, Willemze R & Barge RMY (2005), Minimal GvHD after myeloablative unrelated donor stem cell transplantation using both in vitro and in vivo T-cell depletion with Campath-1H, Bone Marrow Transplantation 35.
- Westerhuis G, Maas WE, Willemze R, Toes REM & Fibbe W (2005), NK-cell tolerance in major mismatched stem cell transplantation, Bone Marrow Transplantation 35.
- Barge RMY, Steel E, Starrenburg CW, Beaumont MF, Smit WM, Schaafsma MR, Fibbe WE, Falkenburg JHF & Willemze R (2005), Toxicity and efficacy of donor lymphocyte infusions for patients with acute myelold leukaemia, Bone Marrow Transplantation 35.
- Schaar CG, Kluin-Nelemans HC, te Marvelde C, le Cessie S, Breed WP, Fibbe WE, van Deijk WA, Fickers MM, Roozendaal KJ & Wijermans PW (2005), Interferon-alpha as maintenance therapy in patients with multiple myeloma, Annals of Oncology 16(4).
- Flierman R, Witteveen H, Van Der Voort E, Huizinga T, De Vries R, Fibbe W, Toes R & Van Laar J (2005), Control of systemic B cell-mediated autoimmune disease by nonmyeloablative conditioning and MHC-mismatched allogeneic bone marrow transplantation, Annals of the Rheumatic Diseases 64.
- van der Mast B, Roelen D, t'Anker PI, Kleijburg C, van Beelen E, de Groot-Swings G, van Schip J, Fibbe W, Kanhai H, Scherjon S & Claas F (2005), The immunomodulatory effect of mesenchymal stem cells derived from the foeto-maternal interface, Placenta 26(8-9).
- Nauta AJ, Kruisselbrink AB, Lurvink E, Mulder A, Claas FH, Noort WA, Willemze R & Fibbe WE (2005), Enhanced engraftment of umbilical cord blood-derived stem cells in NOD/SCID mice by cotransplantation of a second unrelated cord blood unit, Experimental Hematology 33(10).
- Nauta AJ, Lurvink E, Kruisselbrink AB, Willemze R & Fibbe WE (2005), Mesenchymal stem cells inhibit generation and function of both monocyte-derived and CD34-derived dendritic cells., Blood 106(11).
- van Hensbergen Y, de Boer H, Slot MC, Schipper LF, Brand A & Fibbe WE (2005), Mesenchymal stem cells promote the engraftment of cord blood CD34(+) cells but do not accelarate platelet recovery NOD/SCID mice, Blood 106(11).
- Barge RMY, Steel E, Starrenburg I, Beaumont F, Smit WM, Schaafsma MR, Posthuma W, Fibbe WE, Falkenburg F & Willemze R (2005), Adoptive immunotherapy with donor lymphocyte infusions after T-cell depleted allogeneic stem cell transplantation for patients with acute myeloid leukemia, Blood 106(11).
- van Pel M, Hagoort H, Willemze R, Hamann J & Fibbe WE (2005), CD97 is differentially expressed on murine hematopoietic stem cells and progenitor cells., Blood 106(11).
- van Velzen-Ball LM, Le Blanc K, Lankester AC, Roelofs H, Egeler M, Frassoni F, Ringden O & Fibbe WE (2005), Transplantation of haplo-identical bone marrow-derived mesenchymal stem cells together with hematopoietic stem cells to promote engraftment in children - A phase I/II multicenter study, Blood 106(11).
- de Pauw ESD, Roelofs H, Zwinderman A, van Houwelingen JC, Fibbe WE, de Knijff P, Pearson PL & Tanke HJ (2005), Studying the biological and technical sources of variation in telomere length of individual chromosomes, Cytometry Part A 65A(1).
- Beeres SLMA, Zeppenfeld K, Fibbe WE, Bax JJ, van der Laarse A, de Vries T, van der Wall EE, Schalij MJ & Atsma DE (2005), Intramyocardial injection of autologous bone marrow cells in patients with refractory angina pectoris and chronic ischemia is safe, reduces anginal symptoms and improves myocardial perfusion., Journal of the American College of Cardiology 45(3).
- van Oosterhout M, Verburg RJ, Levarht EWN, Moolenburgh D, Bajema I, Barge RY, Fibbe WE & van Laar JM (2005), High-dose chemotherapy and syngeneic stem cell transplantation in a patient with refractory rheumatoid arthritis: poor response associated with persistence of synovial abnormalities, Arthritis Research and Therapy 7.
- Beeres SL, Atsma DE, Pijnappels DA, Beckmann O, van der Laarse A, de Vries AA, Fibbe WE, van der Wall EE & Schalij MJ (2005), Human adult bone marrow-derived mesenchymal stem cells repair experimental conduction block in cardiomyocyte cultures in contrast to skeletal myoblasts and cardiac fibroblasts, Circulation 112(17).
- Beeres SLMA, Atsma DE, van der Laarse A, Pijnappels DA, van Tuyn J, Fibbe WE, de Vries AAF, Ypey DL, van der Wall EE & Schalij MJ (2005), Human adult bone marrow mesenchymal stem cells repair experimental conduction block in rat cardiomyocyte cultures, Journal of the American College of Cardiology 46(10).
- Velders GA, van Os R, Hagoort H, Verzaal P, Guiot HFL, Lindley IJD, Willemze R, Opdenakker G & Fibbe WE (2004), Reduced stem cell mobilization in mice receiving antibiotic modulation of the intestinal flora: involvement of endotoxins as cofactors in mobilization, Blood 103(1).
- Posthuma EFM, Marijt EWAF, Barge RMY, van Soest RA, Baas IO, Starrenburg CWJI, van Zelderen-Bhola SL, Fibbe WE, Smit WM, Willemze R & Falkenburg JHF (2004), alpha-interferon with very-low-dose donor lymphocyte infusion for Hematologic or cytogenetic relapse of chronic myeloid leukemia induces rapid and durable complete remissions and is associated with acceptable Graft-versus-Host disease, Biology of Blood and Marrow Transplantation 10(3).
- Nauta AJ, Roelofs H & Fibbe WE (2004), The role of mesenchymal stem cells in immune modulation and hematopoietic engraftment., Blood Cells, Molecules and Diseases 33(3).
- Anker ESI, Scherjon SA, Devlieger R, Deprest JA, Claas FJH, Fibbe WE & Kanhai HHH (2004), Human fetal membranes as a novel source of mesenchymal stem cells., Journal of the Society for Gynecologic Investigation 11(2).
- Flierman R, Morgan ME, Van Duivenvoorde LM, De Vries RRP, Fibbe WE, Toes REM & Van Laar JM (2004), Nonmyeloablative conditioning with anti-CD40L monoclonal antibody and low-dose total body irradiation followed by allogeneic bone marrow transplantation is effective as treatment for collagen-induced arthritis, Annals of the Rheumatic Diseases 63.
- Flierman R, Witteveen H, van der Voort E, Huizinga T, de Vries R, Fibbe W, Toes R & van Laar J (2004), Effective treatment of collagen-induced arthritis with nonmyeloablative conditioning and MHC-mismatched allogeneic bone marrow transplantation., Arthritis and Rheumatism 50(9).
- Farge D, Passweg J, van Laar JM, Marjanovic Z, Besenthal C, Finke J, Peter HH, Breedveld FC, Fibbe WE, Black C, Denton C, Koetter I, Locatelli F, Martini A, Schattenberg AVN, van den Hoogen F, van de Putte L, Lanza F, Arnold R, Bacon PA, Bingham S, Ciceri F, Didier B, Diez-Martin JL, Emery P, Feremans W, Hertenstein B, Hiepe F, Luosujarvi R, Lara AL, Marmont A, Martinez AM, Cascon HP, Bocelli-Tyndall C, Gluckman E, Gratwohl A & Tyndall A (2004), Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry, Annals of the Rheumatic Diseases 63(8).
- Nauta AJ, Kruisselbrink AB, Willemze R & Fibbe WE (2004), Transplantation of CD34+ cells derived from two unrelated umbilical cord blood units promotes engraftment with one donor predominance, Experimental Hematology 32(7).
- Nauta AJ, Kruisselbrink AB, Noort WA, Willemze R & Fibbe WE (2004), Increased engraftment after transplantation of CD34+ cells derived from two unrelated umbilical cord blood units, Bone Marrow Transplantation 33.
- Flierman R, Morgan L, van Dulvenvoorde L, de Vries RRP, Fibbe WE, Huizinga TJW, Toes REM & van Laar JM (2004), Allogeneic bone marrow transplantation can suppress established and otherwise chronic collagen-induced arthritis after a nonmyeloablative conditioning regimen employing anti-CD40 ligand monoclonal antibody, Arthritis Research and Therapy 6.
- Barge RMY, Marijt WAF, Osanto S, Starrenburg CWJ, Schaafsma MR, Smit WM, Fibbe WE, Falkenburg JHF & Willemze R (2004), High dose of in-vitro T-cell depleted CD34+donor peripheral stem cells after non-myeloablative conditioning accelerates platelet recovery but does not establish complete donor chimerism, Bone Marrow Transplantation 33.
- Roelofs H, Egeler RM & Fibbe WE (2004), Expansion of bone marrow-derived mesenchymal stem cells for clinical application, Bone Marrow Transplantation 33.
- van Hensbergen Y, Schipper LF, Brand A, Slot MC, Noort WA & Fibbe WE (2004), Kinetics of human platelet reconstitution in NOD/SCID-mice following transplantation with ex vivo expanded CD34-positive cord blood cells, Bone Marrow Transplantation 33.
- Roelen DL, in't Anker ES, van Beelen E, van Schip JJ, Kleyburg C, de Groot G, Fibbe WE, Kanhai HHH, Scherjon SA & Claas FHJ (2004), The use of mesenchymal stem cells as a tool for immunomodulation of the alloimmune response in pregnancy and solid organ transplantation, Genes and Immunity 5.
- Westerhuis G, Maas WG, Willemze R, Toes RE & Fibbe WE (2004), Hematopoietic chimerism following non-myeoloablative stem cell transplantation is dependent on NK cell tolerance., Blood 104(11).
- van Pel M, van Os R, Velders GA, Hagoort H, Lindley IJ, Willemze R & Fibbe WE (2004), Alpha-1 antitrypsin is a potent inhibitor of cytokine-induced hematopoietic stem cell mobilization., Blood 104(11).
- Nauta AJ, Kruisselbrink AB, Willemze R & Fibbe WE (2004), Increased engraftment after double cord blood transplantation in NOD/SCID mice., Blood 104(11).
- von dem Borne PA, Beaumont F, Starrenburg I, Oudshoorn MA, Hale G, Falkenburg JHF, Fibbe WE, Willemze R & Barge RMY (2004), Improved long term survival with minimal GVHD after myeloablative unrelated donor stem cell transplantation using in vitro and in vivo T cell depletion with CAMPATH-1H., Blood 104(11).
- in't Anker PS, Scherjon SA, Kleijburg-van der Keur C, de Groot-Swings GMJS, Claas FHJ, Fibbe WE & Kanhai HHH (2004), Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta.
- In't Anker P, Kleijburg-Van Der Keur C, Noort W, Beekhuizen W, Willemze R, Kanhai H, Fibbe W & Scherjon S (2003), Isolation of mesenchymal stem cells from human second-and third-trimester umbilical cord blood, Experimental Hematology 31(7).
- Barge RMY, Marijt EWA, Osanto S, Starrenburg I, Smit WM, Schaafsma MR, Fibbe WE, Falkenburg JHF & Willemze R (2003), Depleted non-myeloablative stem cell transplantation induces rapid conversion to full donor chimerism in patients with high risk malignancies., Blood 102(11).
- in 'tAnker PS, Scherjon SA, Kleijburg-van der Keur C, Noort WA, Claas FHJ, Willemze R, Fibbe WE & Kanhai HHH (2003), Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation, Blood 102(4).
- Keating S, Suciu S, de Witte T, Zittoun R, Mandelli F, Belhabri A, Amadori S, Fibbe W, Gallo E, Fillet G, Varet B, Meloni G, Hagemeijer A, Fazi P, Solbu G & Willemze R (2003), The stem cell mobilizing capacity of patients with acute myeloid leukemia in complete remission correlates with relapse risk: results of the EORTC-GIMEMA AML-10 trial, Leukemia 17(1).
- Barge RMY, Marijt WAF, Osanto S, Starrenburg CWJ, Smit W, Fibbe WE, Falkenburg JHF & Willemze R (2003), Non-myeloablative in vitro T-cell depleted allogeneic stem cell transplantation is a good platform for subsequent cellular immunotherapy in patients with hematological malignancies and solid tumors, Bone Marrow Transplantation 31.
- Segeren CM, Sonneveld P, van der Holt B, Vellenga E, Croockewit AJ, Verhoef GEG, Cornelissen JJ, Schaafsma MR, van Oers MHJ, Wijermans PW, Fibbe WE, Wittebol S, Schouten HC, Kooy MV, Biesma DH, Baars JW, Slater R, Steijaert MMC, Buijt I & Lokhorst HM (2003), Overall and event-free survival are not improved by the use of myeloablative therapy following intensified chemotherapy in previously untreated patients with multiple myeloma: a prospective randomized phase 3 study, Blood 101(6).
- Fibbe WE & Noort WA (2003), Mesenchymal stem cells and hematopoietic stem cell transplantation, Annals of the New York Academy of Sciences 996.
- Noort WA, Kruisselbrink AB, Willemze R & Fibbe WE (2003), Human fetal lung derived mesenchymal stem cells (FL-MSC) inhibit T cell proliferation in mixed lymphocyte cultures or in response to IL-2, Experimental Hematology 31(7).
- van Os R, Velders GA, Hagoort H, van Pel M, van Schie M, Dethmers-Ausema B, de Haan G, Willemze R & Fibbe WE (2003), Protease inhibitors are involved in inhibition of stem cell mobilization induced by low dose irradiation., Blood 102(11).
- Roelofs H, de Pauw ESD, Zwinderman AH, Opdam SM, Willemze R, Tanke HJ & Fibbe WE (2003), Homeostasis of telomere length rather than telomere shortening after allogeneic peripheral blood stem cell transplantation, Blood 101(1).
- In't Anker P, Noort W, Scherjon S, Kruisselbrink A, Beekhuizen W, Willemze R, Kanhai H & Fibbe W (2003), Non-expanded primary lung and bone marrow-derived mesenchymal cells promote the engraftment of umbilical cord blood-derived CD34+cells in NOD/SCID mice, Experimental Hematology 31(7).
- Barge RMY, Osanto S, Marijt WAFE, Starrenburg CWJI, Fibbe WE, Nortier JWRH, Falkenburg JHF & Willemze R (2003), Minimal GVHD following in-vitro T cell-depleted allogeneic stem cell transplantation with reduced-intensity conditioning allowing subsequent infusions of donor lymphocytes in patients with hematological malignancies and solid tumors, Experimental Hematology 31(10).
- 't Anker PS, Noort WA, Kruisselbrink AB, Scherjon SA, Beekhuizen W, Willemze R, Kanhai HHH & Fibbe WE (2003), Nonexpanded primary lung and bone marrow-derived mesenchymal cells promote the engraftment of umbilical cord blood-derived CD34(+) cells in NOD/SCID mice, Experimental Hematology 31(10).
- Schipper LF, Brand A, Reniers N, Melief CJJ, Willemze R & Fibbe WE (2003), Differential maturation of megakaryocyte progenitor cells from cord blood and mobilized peripheral blood, Experimental Hematology 31(4).
- Anker PSI, Noort WA, Scherjon SA, Kleuburg-van der Keur C, Kruisselbrink AB, van Bezoolien RL, Beekhuizen W, Willemze R, Kanhai HHH & Fibbe WE (2003), Mesenchymal stem cells in human second-trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential, Haematologica 88(8).
- Roelofs H, Noort W, Zwinderman A, Willemze R & Fibbe W (2002), Factors inherent to the cord blood stem cell graft determine telomere dynamics after transplantation to NOD/SCID mice, Experimental Hematology 30(6).
- de Pauw ESD, Otto SA, Wijnen JT, Vossen JM, van Weel MH, Tanke HJ, Miedema F, Willemze R, Roelofs H & Fibbe WE (2002), Long-term follow-up of recipients of allogeneic bone marrow grafts reveals no progressive telomere shortening and provides no evidence for haematopoietic stem cell exhaustion, British Journal of Haematology 116(2).
- Noort WA, Kruisselbrink AB, in't Anker PS, Kruger M, van Bezooijen RL, de Paus RA, Heemskerk MHM, Lowik CWGM, Falkenburg JHF, Willemze R & Fibbe WE (2002), Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD/SCID mice, Experimental Hematology 30(8).
- Velders GA, Pruijt JFM, Verzaal P, van Os R, van Kooyk Y, Figdor CG, de Kruijf EJFM, Willemze R & Fibbe WE (2002), Enhancement of G-CSF-induced stem cell mobilization by antibodies against the beta 2 integrins LFA-1 and Mac-1, Blood 100(1).
- Iestra JA, Fibbe WE, Zwinderman AH, van Staveren WA & Kromhout D (2002), Body weight recovery, eating difficulties and compliance with dietary advice in the first year after stem cell transplantation: a prospective study, Bone Marrow Transplantation 29(5).
- Hazenberg MD, Otto SA, de Pauw ES, Roelofs H, Fibbe WE, Hamann D & Miedema F (2002), T-cell receptor excision circle and T-cell dynamics after allogeneic stem cell transplantation are related to clinical events, Blood 99(9).
- Barge RMY, Marijt E, Osanto S, Starrenburg I, Smit W, Fibbe WE, Falkenburg JHF & Willemze R (2002), A two step non-myeloablative allogeneic (NM-allo) transplantation strategy using in vitro T-cell depleted G-CSF mobilized peripheral blood stem cells followed by donor lymphocyte infusions (DLI)., Blood 100(11).
- Fibbe WE (2002), Mesenchymal stem cells. A potential source for skeletal repair, Annals of the Rheumatic Diseases 61.
- Pruijt JFM, Verzaal P, van Os R, de Kruijf EJFM, van Schie MLJ, Mantovani A, Vecchi A, Lindley IJD, Willemze R, Starckx S, Opdenakker G & Fibbe WE (2002), Neutrophils are indispensable for hematopoietic stem cell mobilization induced by interleukin-8 in mice, Proceedings of the National Academy of Sciences 99(9).
- Verburg RJ, Toes REM, Fibbe WE, Breedveld FC & van Laar JM (2002), High dose chemotherapy and autologous hematopoietic stem cell transplantation for rheumatoid arthritis: A review, Human Immunology 63(8).
- Van Os R, Van Schie MLJ, Willemze R & Fibbe WE (2002), Proteolytic enzyme levels are increased during granulocyte colony-stimulating factor-induced hematopoietic stem cell mobilization in human donors but do not predict the number of mobilized stem cells, Journal of Hematotherapy and Stem Cell Research 11(3).
- Anker PSI, Noort WA, Scherjon SA, Kleijburg-van der Keur C, Kruisselbrink AB, Beekhuizen W, Willemze R, Kanhai HH & Fibbe WE (2002), Characterization of mesenchymal stem cells in human second-trimester bone marrow, liver, lung and spleen., Blood 100(11).
- Anker PSI, Noort WA, Scherjon SA, Kruisselbrink AB, Beekhuizen W, Willemze R, Kanhai HH & Fibbe WE (2002), Non-expanded primary mesenchymal stem cells promote the engraftment of umbilical cord blood-derived CD34(+) cells in NOD/SCID mice., Blood 100(11).
- Roelofs H, Bredius RGM, Waaijer JL, Vossen JMJJ, Willemze R & Fibbe WE (2002), Telomere length after allogeneic bone marrow transplantation in children with severe combined immunodeficiency disease., Blood 100(11).
- Verdijk RM, van Nieuwkoop JA, Fibbe WE & Brand A (2002), Reinfusion of autologous thrombocytes recovered from peripheral blood stem cell (PBSC) harvests in healthy related donors enables multiple day large volume harvesting., Blood 100(11).
- Noort WA, Kruissetbrink AB, Anker PSI, Willemze R & Fibbe WE (2002), Co-transplantation of mesenchymal stem cells (MSC) enhances engraftment by promoting the homing of cord-blood derived CD34 cells in NOD/SCID mice, Blood 100(11).
- Fibbe WE, Noort WA, Schipper F & Willemze R (2001), Ex vivo expansion and engraftment potential of cord blood-derived CD34(+) cells in NOD/SCID mice, Annals of the New York Academy of Sciences 938.
- van Laar JM, Verburg RJ, Fibbe WE & Breedveld FC (2001), Intensive immunosuppression and autologous stem cell transplantation for patients with severe rheumatoid arthritis: The Leiden experience, Journal of Rheumatology 28.
- Vellenga E, van Agthoven M, Croockewit AJ, Verdonck LF, Wijermans PJ, van Oers MHJ, Volkers CP, van Imhoff GW, Kingma T, Uyl-de Groot CA & Fibbe WE (2001), Autologous peripheral blood stem cell transplantation in patients with relapsed lymphoma results in accelerated haematopoietic reconstitution, improved quality of life and cost reduction compared with bone marrow transplantation: the Hovon 22 study, British Journal of Haematology 114(2).
- Barge RMY, Brouwer RE, Beersma MFC, Starrenburg CWJ, Zwinderman AH, Hale G, Waldmann H, den Ottolander GJ, Falkenburg JHF, Willemze R & Fibbe WE (2001), Graft outcome - Comparison of allogeneic T cell-depleted peripheral blood stem cell and bone marrow transplantation: effect of stem cell source on short-and long-term outcome, Bone Marrow Transplantation 27(10).
- Verburg RJ, Kruize AA, van den Hoogen FHJ, Fibbe WE, Petersen EJ, Preijers F, Sont JK, Barge RMY, Bijlsma JWJ, van de Putte LB, Breedveld FC & van Laar JM (2001), High-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with rheumatoid arthritis - Results of an open study to assess feasibility, safety, and efficacy, Arthritis and Rheumatism 44(4).
- van Agthoven M, Vellenga E, Fibbe WE, Kingma T & Uyl-de Groot CA (2001), Cost analysis and quality of life assessment comparing patients undergoing autologous peripheral blood stem cell transplantation or autologous bone marrow transplantation for refractory or relapsed non-Hodgkin's lymphoma or Hodgkin's disease: a prospective randomised trial, European Journal of Cancer 37(14).
- Lokhorst HM, Schattenberg A, Cornelissen JJ, van Oers MHJ, Fibbe W, Russell I, Van der Donk NWCJ & Verdonck LF (2000), Donor lymphocyte infusions for relapsed multiple myeloma after allogeneic stem-cell transplantation: Predictive factors for response and long-term outcome.
- Hale G, Jacobs P, Wood L, Fibbe WE, Barge R, Novitzky N, du Toit C, Abrahams L, Thomas V, Bunjes D, Duncker C, Wiesneth M, Selleslag D, Hidajat M, Starobinski M, Bird P & Waldmann H (2000), CD52 antibodies for prevention of graft-versus-host disease and graft rejection following transplantation of allogeneic peripheral blood stem cells.
- Fibbe WE, Pruijt JFM, van Kooyk Y, Figdor CG, Opdenakker G & Willemze R (2000), The role of metalloproteinases and adhesion molecules in interleukin-8-induced stem-cell mobilization.
- Broers S, Kaptein AA, Le Cessie S, Fibbe W & Hengeveld MW (2000), Psychological functioning and quality of life following bone marrow transplantation: A 3-year follow-up study.
- lid
- lid
- redactielid
- Lid
- Lid
- voorzitter
- bestuurslid
- lid
- redacteur
- redacteur
- redactielid
- co-voorzitter
- redactielid
- voorzitter
- voorzitter Hematology Working Group